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November 27, 1967 
To Members of the Forty-sixth Colorado General Assembly: 
In accordance with provisions of Senate Joint 
Resolution No. 42, 1967 session, the Legislative Council 
submits the accompanying report and recommendations re-
lating to the subject of dangerous drugs and drug abuse 
in Colorado. 
The report and recommendations of the committee 
appointed to carry out this study was accepted by the. 
Council at its meeting on November 27, 1967, for trans- _ 
mission to the members of the second regular session of 
the Forty-sixth General Assembly. The Legislative 
Council has requested that the Govemor include the 
recommended bill among the items for consideration in 
the second session of the Forty-sixth General Assembly. 
CPL/mp 
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Representative C. P. Lamb, Chairman 
Colorado Legislative Council 
Room 341, State Capitol 
Denver, Colorado 
Dear Mr. Chairman: 
MEMBERS 
LT, GOV. MARK HOGAN 
SEN, FAY Dt:BERARD 
BEN. FRANK KEMP 
SEN. VINCENT MAl!IBARI 
SEN, RUTH STOCKTON 
SPEAKER JOHN D, 
VANDERHOOF 
REP, BEN KLEIN 
REP, RAY BLACK 
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REP, RAYMOND WILDER 
In accordance with the provisions of Senate Joint Resolution 
No. 42, 1967 session, your Committee on the Criminal Code was ap-
pointed to continue the work on revision of Colorado criminal laws, 
to review recommendations of the President's Commission on Crime, 
to study all aspects of sentencing of offenders, and to make recom-
mendations concerning the need for legislation controlling dangerous 
drugs and drug abuse in Colorado. 
Although the committee is not required to report its findings 
and recommendations until 1969, its work has been completed in re-
gard to dangerous drugs and drug abuse, and the committee submits 
the accompanying report and recommendations to the Legislative 
Council. Because of the seriousness of the drug abuse problem and 
the need for the state to begin drug treatment programs as well as 
drug control measures, the committee recommends that the Legislative 
Council request that the Governor place this subject in his call to 
the 1968 session of the General Assembly. 
The committee has agreed to submit one bill to control the 
manufacture, sale, distribution, and possession of certain stimu-
lant, depressant, and hallucinogenic drugs. In addition, the bill 
has been prepared to allow the courts the widest possible latitude 
in providing treatment of persons who possess these dangerous drugs 
for personal consumption. 
REW/mp 
Re~p. e. )tfullyl'·~~.mi/tted\··• 
( 
/ i ', \ I L 
( ,., ·1 . c·--- I :,1 . 
. J_., I ,u-,,~ t , -- . ,_ \ ._,l(_ t.-\.. l__ 
Repre~entative Raymond E. Wilder 
Chairman 
Crimi~al Code Committee 
FOREWORD 
The Legislative Council's Criminal Code Committee was cre-
ated pursuant to the provisions of Senate Joint Resolution No. 42, 
1967 regular session, to study revision of Colorado's criminal laws, 
to review recommendations made by the President's Commission on 
Crime, to consider all aspects of sentencing of offenders, and to 
make recommendations concerning the need for dangerous drug legis-
lation. The members appointed to the committee were: 
Rep. Raymond E. Wilder, 
Chairman 
Rep. Ben Klein, Vice 
Chairman 
Sen. David Hahn 
Sen. Ruth Stockton 
Sen. Anthony F. Vollack 
Rep. Thomas Bastien 
Rep. Ted Bryant 
Rep. John Fuhr 
Rep. J. D. Macfarlane 
Rep. Phillip Massari 
Rep. Harold McCormick 
Rep. Hubert M. Safran 
Representative C. P. Lamb, Chairman of the Legislative Council, 
also served as an ex officio member of the committee. 
Early in the committee deliberations, the members agreed 
that the assignment in Senate Joint Resolution No. 42 was greater 
than could be undertaken at one time. Therefore, the committee 
decided to concentrate its efforts first on the subject of drugs and 
drug abuse, since this topic was the only assignment which called 
for specific legislative recommendations. 
The committee wishes to express its appreciation to the 
numerous local, state, and federal officials, and to the several 
professional persons who conferred with the committee on the dang-
erous drug problem. 
Phillip E. Jones and Stanley Elofson, senior research anal-
ysts for the Legislative Council, had the primary responsibility for 
the staff work on this study, with the assistance of Ed Isern, re-
search assistant. James C. Wilson, Jr., and Robert Holt, assistant 
attorneys general, Legislative Reference Office, had the primary 
responsibility for bill drafting services provided the committee. 
November 28, 1967 
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Lyle C. Kyle 
Director 
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CONMITTBE FINDINGS AND RSCOMMBNDATl~S 
The Legislative Council'• Criminal Code Co•ltte• waa ••i•b• 
liehed pureuant to Senate Joint Reeolution No. 42 (1967 Se11ton) 
which directed the Council to conduct a study to ,utMalt Hport, and 
reco•endationa pertaining to problems of drug abu1e in Colorado. 
The atudy of drug abuse wa1 to include the following 1ubject11 
(l) The collection of information and the dev.lopaent ef 
recommendation• pertaining to the eff.ectivene11 of Pf•••nt stat• 
,tatutes and the relation1hip of atate law to federal acts in the 
area of drug control; 
(2) The poasible need for additional at•te legi1lation to 
provide effective control over illicit drug traffic, drug abU1e, and 
drug addiction; 
(3) The determination of the moat 1uitable approach of stat• 
legislation toward the problem of the control of non-narcotic drllf•• 
including stimulants, depressants, and hallucinogenic drugas 
(4) Consideration of the appropriate typea of reaea~ch and 
educational programs that should be undertaken conceming the effect, 
of auch druga upon the human body; and 
(5) A review of the exi1ting treatment facilities avallablt 
for drug users and addicts and the poesible need for additional 
therapeutic facilities to provide more effective control over th• ~. 
uae of drug• within the atate. ~ · 
Although the report of the Criminal Code Committee is not due until 
the 1969 session, the topics listed above have been carefully re-
viewed by the Criminal Code Committee and are considered to be of 
such importance that they merit consideration by the General Assembly 
in the 1968 session. 
In addition to the drug problem, the assignment to the Legia• 
lative Council in S.J.R. 42 directed studiea in three other major 
areas of concern to the criminal laws in this state: 
(1) A study to determine whether legislative efforts to re-
vise and codify the state's criminal laws should be continued, with 
a request being made of members of the Colorado Bar Aasociation, 
faculty members of the law schools in this state, and other inter-
ested persons to evaluate the contents of the preliminary criminal 
1aw revision published in 1964 by the Legislative Council. 
(2) A 1turly to review the report of the President's Coaala• 
1lon on Cri• and to reco11111end appropriate action that should be 
taken by the General Assembly to implement the findings and conclu~ 






ing on the 
A study of all aspects of the subject of sentencing of 
including a review of action taken in the First Regular 
the Forty-sixth General Assembly that would have a bear-
issue of indeterminate sentencing of offenders. 
It is the committee's plan to study the three remaining subjects 
next year and to submit its report and recommendations on these 
topics for consideration in the 1969 session. 
Because the problem of drug abuse was the only specific topic 
directed under S.J.R. No. 42, the committee decided at its June 8 
meeting to undertake its study of the drug abuse problem in Colorado 
as its first matter of concern. The next meetings, June 28 - 29, 
July 18, and September 7, were devoted to hearings on drug abuse. 
Conferees at these meetings represented training in a variety 
of professions, academic disciplines, and practical experiences with 
problems of drug abuse throughout the country and in Colorado. Some 
strong differences of opinion characterized the statements of the 
conferees in regard to the proper approach of state legislation to 
the drug abuse problem. Much of the information in this report was 
provided by the conferees. An outline of some additional viewpoints 
of these conferees is included in the background report which fol-
lows the committee's report. A listing of the conferees and their 
responsibilities follows: 
Mr. John A. Trainor, Denver Office District Supervisor, 
Bureau of Narcotics, U.S. Department of Treasury 
Mr. John Healey, District Supervisor, Bureau of Drug· 
Abuse Control, Food and Drug Administration, U.S. 
Department of Health, Education and Welfare 
Mr. Donald Fletcher, Manager of Distribution Protec-
tion, Smith Kline & French Laboratories, Philadelphia, 
Pennsylvania 
Dr. Hans Schapire, Chief of Psychiatric Services, 
Colorado Department of Institutions 
Mr. Harry Tinsley, Chief of Corrections, Colorado 
Department of Institutions 
Mr. Edward W. Grout, Executive Director, Division of 
Adult Parole, Colorado Department of Institutions 
Dr . Lewis Barbato, Director, Health Services, Univer-
sity of Denver 
Dr. Alan Frank, Psychiatrist, Student Health Services, 
University of Colorado 
Mr. Lester Thomas, Director of Research and Programming, 




Mr. John Gray, Detective, Intelligence Bureau, Denver 
Police Department 
Mr. Leonard Davies, Attorney, Neighborhood Law Center, 
Denver 
Mr. Orlen Wiemann, Chief, Milk, Food, and Drug Section, 
Colorado Department of Public Health 
Professor Richard H. Blum, Project Director, Psycho-
pharmacology Project, Institute for the Study of Human 
Problems, Stanford University 
Dr. H. Peter Metzger, Research Associate, Department of 
Chemistry, University of Colorado 
Mr. Joseph C. Arnold, Minister, United Church of Christ, 
Denver 
Need for Additional State Legislation to Control Dangerous Drugs 
Because of an apparent rapid growth of drug abuse in Colorado, 
particularly by adolescents, the committee has concluded that there 
is a definite need for state legislation to control dangerous 
drugs • .!/ Reliable figures on drug abuse growth are virtually im-
possible to obtain for a number of reasons, and any statistics that 
are presented should be carefully analyzed before being accepted. 
Both proponents and opponents of the use of dangerous drugs tend to 
exaggerate the figures on the number of people using these drugs as 
a method of asserting their cause. However, as one indication of 
significant drug use in Colorado, hardly a day passes without an 
article in the newspapers concerning drug abuse arrests or statements 
concerning drug use. 
The federal government presently controls interstate and in-
trastate manufacturing and distribution of dangerous drugs through 
the Bureau of Drug Abuse Control, Department of Health, Education and 
Welfare. While the federal government can confiscate dangerous 
drugs, federal statutes provide neither penalties nor treatment pro-
grams for individuals possessing these drugs. One of the limitations 
in relying exclusively on the federal government for enforcement of 
y The term "dangerous drugs," as used in this report, refers to 
depressant, stimulant,and hallucinogenic drugs but does not re-
fer to narcotic drugs which are considered as a separate cate-
gory. A description of these drugs is found on page xv of the 





drug abuse laws is that there are relatively few federal agents 
available to control all aspec~s of dangerous drug abuse. Speaker& 
from federal agencies urged the committee to recommend state legis-
lation in order to provide for increased manpower and for sharing of 
information between federal, state, and local authorities. 
It would not be realistic to suggest that state legislation 
on dangerous drugs, even coupled with existing federal laws, will 
eliminate or prevent future problems of drug abuse in Colorado. As 
members of the General Assembly are aware, legislation in dangerous 
drugs control is difficult because of the potential for misuse of 
practically any substance. It was pointed out to the committee that 
legislation to control drug use will always lag behind many new 
drugs with which young people will experiment. 
However, Professor Richard H. Blum of Stanford University 
pointed out that legislation can retard the expansion of drug abuse 
in two ways. First, the availability of dangerous drugs can be re-
duced through legislation. Further, legislation can establish legal 
restrictions which many persons will not want to violate. The com- 1 
mittee believes that legislation to retard further extension of the 
use of dangerous drugs is a matter for serious legislative atten-
tion. The problem, however, becomes one of deciding on the most 
appropriate course of action in the control of drug abuse. 
Alternative Solutions to the Dangerous Drug Abuse Problem 
The committee concluded that it had the choice of recommend-
ing four alternative approaches for legislation. The first alterna-
tive would be to maintain the status quo, or make no recommendations. 
The committee felt that making such a recommendation would be an 
irresponsible position because of the apparent growth of drug abuse 
in Colorado. Although there is much yet to be learned concerning 
long-term effects of dangerous drugs on the human body, the poten-
tial dangers and misuse of these drugs outside of laboratories seems 
sufficient reason to legislate against manufacture, sale, and dis-
tribution of these drugs. 
A second alternative for legislation could be to simply add 
a list of dangerous drugs to the existing statutory definitions of 
narcotic drugs in section 48-5-1, C.R.S. 1963. This approach would 
place dangerous drugs in the same category as narcotic drugs with 
the same penalties for narcotic drugs also applying to dangerous 
drugs. The committee rejected this alternative because of the 
severity of penalties in the narcotic statutes. It was thought that 
the majority of the dangerous drug offenders were young people who 
are potentially productive members of society, but who may be in 
need of guidance, counseling, and treatment, and who probably do not 
realize the significance of a felony stigma. Society probably 
would gain nothing by making these adolescents and young adults 
felons. Once a person is convicted of a felony, the stigma is pres-
ent for the rest of that person's life, and his productive capabili-
ties for further education and future employment might be lost. 
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The third alternative discussed by the committee was to pre-
pare an all-inclusive drug bill. This alternative could combine 
narcotic drugs and dangerous drugs in one act but could have sepa-
rate penalty sections for narcotic drugs and dangerous drugs. One 
potential difficulty which an all-inclusive act could avoid would 
be possible duplication of duties by two different governmental 
agencies. This situation is present on the federal level with the 
Bureau of Narcotics in the Department of Treasury controlling nar-
cotics andthe Bureau of Drug Abuse Control established under the 
Department of Health, Education and Welfare working with dangerous 
drugs. 
The committee believes that a single narcotic-dangerous drug 
act would present the General Assembly with the same controversy 
which the committee constantly faced, namely whether marihuana 
should be listed in the dangerous drug classification or should be 
left in the narcotics classification. As discussed later, there are 
reasons for arguing for removal or for the retention of marihuana 
in the narcotics statutes, but the committee's recommendation is 
that the dangerous drug bill be enacted regardless of any other leg-
islative action in regard to marihuana. 
The fourth alternative, which the committee felt to be the 
best course of action, is a drug abuse act, separate from the nar-
cotic act, controlling dangerous drugs only. The important features 
of the bill which the committee recommends are discussed next. 
Important Features of the Recommended Drug Abuse Control Act 
The committee basically adopted the provisions of the Model 
Drug Abuse Control Act promulgated by the U.S. Department of Health, 
Education and Welfare. This act has been enacted in 14 other states 
(see Item B in the appendix). The proposed drug abuse control act 
for Colorado corresponds closely with the federal law on dangerous 
drugs. This uniformity makes it easier for legitimate manufacturers, 
wholesalers, and distributers, which are required to be licensed, to 
comply with the provisions of the dangerous drug law. Better coop-
eration between state& and local authorities and federal officers 
can be achieved if state legislation is in agreement with federal 
law. 
Controlled Dangerous Drugs. !he dangerous drugs controlled 
by the recommended act include a number of specified depressant 
drugs (sleep inducing dru9s), stimulant drugs (drugs which induce 
alertness and wakefulness), and hallucinogens (drugs which distort 
perceptions of the mind). The list of controlled drugs in each 
category is taken from federal statutes and from the federal regu-
lations of the Food and Drug Administration which is authorized by 
federal law to list additional drugs having a potential for abuse 
because of their depressant, stimulant, or halluc5nogenic effect. 
The sources for the drugs listed in the three categories are noted 
in the comment portion of the bill which follows thi~ report. It 
was necessary to specify the controlled drugs in the bill instead 
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of permitting the administrative authoritiea to prepare the danger• 
oua drug liat. This procedure will avoid a constitutional question 
of unlawful delegation of authority, since the proposed bill in-
cludes criminal penalties. 
Two exceptions to these claaaificationa of drugs ahould be 
noted. Cocaine, a strong stimulant! is included in the narcotic 
drug category rather than in the st mulant drug claasification. 
However, cocaine may produce possible toxic reactions so it is sel-
dom abuaed and presents no controversy. 
The committee was divided on the question of whether to leave 
marihuana as a narcotic drug or to reclassify it as a hallucinogenic 
drug in the dangerous drug bill. Votes on this question were taken 
on four occasions in committee meetings, the result of three of the 
votes being not to reclassify marihuana as a dangerous drug. The 
committee recommendation is that marihuana be left unchanged in the 
narcotic drug classification at least until the issue is clarified 
on the basis of further research by the federal government. 
Several arguments for and against retention of marihuana 
under the state's narcotic law were presented to the committee. In-
dividuals advocating a raclassification of marihuana as a dangerous 
drug point out that marihuana is a narcotic by legal definition 
only. Pharmacologists have stated that marihuana is a mild halluci-
noger., much weaker than LSD which is classified as a dangerous hal-
lucinogenic drug in the proposed bill. It was also stated that both 
alcohol and cigarettes may be potentially more dangerous than mari-
huana. 
Arguments for leaving marihuana in the narcotics listing were 
that every other state has defined marihuana as a narcotic drug and• 
evm though the federal law has not defined marihuana as a narcotic 
drug, marihuana is treated the same as a narcotic drug. If mari-
huana were made a dangerous drug, jurisdictional disputes could de-
velop between the federal Bureau of Narcotics and the state. There-
fore, until the federal government reclassifies marihuana, it would 
not be practical for Colorado to place marihuana in the dangerous 
drug category. Two important features of drug control laws are 
uniformity in statutes and cooperation between state and federal 
officers. Further, removal of marihuana to the dangerous drug 
category, with weaker penalties than the narcotic laws, might be 
misinterpreted as an expression of tacit approval for the use of the 
drug. After much deliberation, the committee decided not to recom-
mend reclassifying marihuana for the reasons discussed above. 
Unlawful Acts. The proposed bill would make illegal manu-
facturing, sale or aistribution, and possession of dangerous drugs 
unlawful acts. To assure that control over these drugs is main-
tained, the bill includes regulations for making detailed prescrip-
tions for legal possession. All manufacturers, wholesalers, and 
anyone else handling these drugs would be licensed or registered 
under this act except for physicians, pharmacists, dentists, and 
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veterinarians who are licensed by their respective professional li-
censing boards. Everyone licensed under this act or by a profes-
sional licensing board would be required to keep records of sale of 
dangerous drugs for two years, and these records of sale and all 
inventory supplies would be open to inspection to authorized state 
officials. These provisions would assist in controlling both pro-
duction and distribution of dangerous drugs. Anyone violating any 
of the record keeping requirements or licensing procedures could 
have his professional license or the license issued under this act 
suspended or revoked. 
Penalties. The committee agreed that the most significant 
problem in dangerous drugs was to dry up the illicit sources of 
dangerous drugs. Strict criminal sanctions should be applied for 
the illegal manufacture, sale, possession with intent to sell, and 
the attempt to sell any listed dangerous drug. These offenses 
should be felonies with possible imprisonment in the state peniten-
tiary from one to fourteen years and a fine of up to $1,000. 
The penalty for unlawful possession, however, was a problem 
of great concern to the committee. During the hearings several ex-
perts in the field of dangerous drugs testified that a great ma-
jority of the drug users were adolescents or young adults who took 
drugs on an experimental basis. Many of these persons may take drugs 
one time as a method of adventuring into the world away from paren-
tal control. The young people who continue to use dangerous drugs 
were said to do so primarily because of some deep-seated emotional 
problem. Young persons using drugs should not be deterred from seek-
ing medical assistance because of fear of criminal penalty. 
With this background in mind, the committee provided three 
penalties for unlawful possession of dangerous drugs. The first two 
offenses would be misdemeanors with several alternative provisions 
for education and treatment of the offender. For the first offense 
the judge would have the alternatives of (1) sentencing the offender 
to county jail, (2) fining the offender, (3) both fine and sentence, 
(4) granting probation, (5) granting conditional probation, (6) 
deferring trial in case of voluntary commitment for treatment, and 
(7) proceeding under civil (involuntary) commitment. For the second 
offense a person could be (1) sentenced to the county jail for a 
period of time up to two years, (2) fined up to a maximum of $1,000 
or (3) both imprisoned and fined. The judge is also given authority 
to (4) place the defendant in the care and custody of the department 
of institutions (involuntary civil commitment), or (5) to grant pro-
bation. The third offense is a felony with provisions for imprison-
ment in the state penitentiary for a period of from one to fourteen 
years, or to provide for involuntary commitment, or grant probation. 
The committee believes that legislation to control the avail-
ability of dangerous drugs by strict penalties for illegal drug 
production and distribution represents a better use of the limited 
manpower for police purposes than prosecuting drug users. 
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other Committee Recommendations 
Education. During the hearings in June and July, every con-
feree pointed out that society as a whole lacks the proper knowledge 
about the dangers of drug abuse. It was stated that the United 
States has become a "pill addicted socei ty" in which drugs are used 
when persons catch cold, become nervous, or gather socially, (alco-
hol is a depressant drug). It should not be unexpected that young 
people are using drugs, since they are imitating their parents. The 
primary difference is that parents use legal drugs and young people 
use exotic illegal drugs. 
It would be impossible to educate all of society; however, 
several segments of society can be educated. For example, medical 
doctors are the leaders in forming drug habits through prescribing 
drugs and need to be informed of drug abuse trends. Police officers 
have been given the impossible task of controlling drug traffic and 
use. However, there is need for more training for police officers 
particularly in regard to the effects of drugs, why people use drugs, 
and the availability of treatment facilities. The committee was told 
that the police are directed to get the drug abuser off the street, 
and with the limited tool of arrest available to them, they have done 
a good job. However, this approach does not keep the drug abuser 
off the street permanently. 
Finally, school children need a good drug education program 
in the schools. It was emphasized to the committee that young people 
often do not understand that drug use can be dangerous. An educa-
tional program should start in the latter years of elementary school 
with at least one hour per semester and should be taught by•well in-
formed teachers using factual, ·current information. Several sources 
of materials for schools were mentioned as being available for the 
teaching of a well rounded and factual drug education program. 
State Laboratory. Federal authorities suggested that Colorado 
establish a laboratory available to law enforcement agencies for 
drug identification, possibly under the supervision of the Colorado 
Bureau of Investigation. Law enforcement agencies currently have to 
send drug samples to the laboratories of the Federal Bureau of In-
vestigation, the Bureau of Narcotics, the Bureau of Drug Abuse Con-
trol, or the Denver Police Department. Often these agencies are not 
able to immediately analyze drug samples, and a long delay in re-
ceiving the analysis may mean that a drug case is dismissed or the 
defendant loses his right to a speedy trial. 
Narcotic Dru1s. The 1960 Federal Narcotics Law, "Narcotic Manufacture Act of960," removed from the exempt list dihydrocodei-
none. In Section 48-5-8, C.R.S. 1963, dihydrocodeinone is still 
exempt. Since federal law takes precedence, Colorado should revise 
Section 48-5-8 to conform with federal law. 
Treatment Facilities. Colorado is a growing state, and 
growth can bring narcotic problems. The treatment facilities in 
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Colorado are limited to some emergency treatment facilities, one 
facility for treatment of acute withdrawal symptoms, which is more 
than most states have, and the Colorado State Hospital for control-
led withdrawal and therapy. 
The committee recommends that a specialized facility be estab-
lished for treatment of narcotic addicts and persons needing care 
for the use of dangerous drugs. This drug treatment ward should be 
separate from other treatment facilities and should be staffed by 
persons interested and skilled in the treatment of drug addiction 
and dependency. It is further suggested that this facility be lo-
cated in the Denver area so that it will be accessible to the largest 
population center in the state in providing both inpatient and ambu-
latory services. 
A major deficiency in the st~te's treatment program is the 
lack of aftercare facilities close to an addict's home. When the 
addict returns to the same environment where he became addicted, he 
will become readdicted when the problems of his environment again 
present themselves. The American Medical Association supports a pro-
gram of withdrawal in a controlled drug free environment, and a full 
program of aftercare, including regular and surprise physical tests 
on the addict. Much of the aftercare work can be carried on by the 
state's social services. To aid the states Congress passed the 
"Narcotic Rehabilitation Act of 1966," which makes funds available 
to the states to build and maintain treatment facilities. Colorado 




A BILL FOR AN ACT 
CONCERNING CERTAIN DRUGS NOT REGULATED BY ARTICLE 5 OF 
CHAPTER 48, COLORAOO REVISED STATUTES 1963 AS AMENDED, 
AND PROVIDING FOR THE REGULATION OF CERTAIN DEPRES-
SANT, STIMULANT, AND HALLUCINOGENIC DRUGS AS DEFINED 
IN THIS ACT. 
h ,.ti enacted !ri the General Assembl"( 91.. ~ State ll Colo-
rado: -
SECTION 1. Definitions. (l) As used in this act, 
unless the context otherwise indicates: 
(2) (a) woepressant drugsfl means: 
(b) Barbituric acid, allylbarbituric acid, aprobar-
bital, beta-bromoallyl, secondary - amylbarbituric acid, 
butallylonal, diallyl barbituric acid, barbital, hexobar-
bital, dipropylbarbituric acid, butethal, butabarbital, 
cyclobarbital, hexethal, amobarbital, pentobarbital, thi-
opental, vinbarbital, mephobarbital, propallylonal, phenyl-
methylbarbituric acid, secobarbital, phenobarbital, pro-
barbital, and their salts; and 
Q)M\fENTS 
The sour-::;• for all enumerated 
drugs is ~ne Code of Federal 
Re~ulations, Title 21, parts 
16 and 166. This drug list 
will need to be updated an-
nually by the General Assembly 
as new drugs are cont.rolled 
by the Food and Dru9 Adminis-
tration. These additional 
drugs will be listed in the 
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(c) Bromal hydrate, bromoform, tribromo, chloral 
hydrate, chloralimide, chloralformamide, chloralose, chlor-
butanol, acetylcarbromal, bromisovalum, diethylbromo aceta-
mide, ethchlorvynol, ethinamate, glutethimide, methyprylon, 
paraldehyde, lysergic acid, lysergic acid amide, chloral 
betaine, chlorhexadol, petrichloral, sulfondiethylmethane, 
sulfonethylmethane, sulfonmethane. 
(3) "Stimulant drugs" means d-amphetamine, del-amphe-
tamine, d-methamphetamine, dl-methamphetamine, d-desoxye-
phedrine, dl-desoxyephedrine, and phenmetrazine, and their 
salts. 
(4) "Hallucinogenic drugs" means dimethyltryptamine, 
d-lysergic acid diethylamide, mescaline and its salts, 
peyote, psilocybin, and psilocyn. 
(5) •Dangerous drug" shall mean depressant drugs, 
hallucinogenic drugs, or stimulant drugs, or any of such 
drugs in a mixture, compound, or with any .other substance. 
(6) "Practitioner" means a person authorized by the 
laws of this state to practice medicine, veterinary medicine, 
CQM\IENTS 
Under the pharmacy laws of 
this state, the board of phar-
macy has control, by inspec-
tion, over-all prescription 
drugs, which include many sti-
mulants and depressants. How-
ever, this control is limited 
to the retail level, including 
institutional pharmacies. Phy-
sicians are excluded from in-
spection by the state board of 
pharmacy and manufacturers, 
wholesalers, and warehousemen 
are not now regulated under 
Colorado pharmacy laws. These 
persons would be regulated 
under this act insofar as the 
specific drugs listed in the 
act are concerned. 
or dentistry, in this state or any other person who is au-
thorized by the laws of this state to prescribe drugs. 
(7) "Pharmacist" means a registered pharmacist as 
defined by the laws of this state, and, where the context 
requires, the owner of a sto~or other place of business 
where drugs are compounded or dispensed by a registered 
pharmacist; but nothing in this subsection shall be construed 
as conferring on a person who is not registered nor licensed 
as a pharmacist any authority, right, or privilege, that is 
not granted to him by the pharmacy laws of this state. 
(8) "Manufacturer" means a person who by compounding, 
mixing, cultivating, growing, or other process, produces 
or prepares dangerous drugs for dispensing, but does not 
include a pharmacist who compounds dangerous drugs to be 
sold or dispensed. 
(9) •wholesaler• means a person who dispenses, with-
out prescription, dangerous drugs that he himself has not 
prepared or produced. 
(10) •·. Warehouseman" means a person who stores or 
COf:MENIS 
dispenses dangerous drugs for others and who has no control 
over the disposition of such drugs except for the purpose 
of such storage or dispensing. 
(11) "Carrier" means any person who transports danger-
ous drugs iu the ordinary course of his business for any 
person required to be licensed pursuant to section 6 of this 
act. 
(12) •clinical researcher• means · any person licensed 
pursuant to section 6 of this act to experiment with, study, 
or test any dangerous drug within this state. 
(13) "Hospital• means an institution for the care and 
treatment of the infirm, sick, and injured, approved by 
an agency· of this state to be entrusted with the custody.of 
narcotic drugs and the professional use of narcotic drugs 
under the direction of a practitioner. 
(14) •Person• means an individual, partnership, corpo-
ration, or association. 
(15) "Dispense• means sale, delivery, giving away, or 
supplying in any other manner, or otherwise disposing of 
CQMfflITS 
to another person. 
(16) •soard• means the state board of pharmacy. 
SECTia-J 2. Unlawful acts. (1) Except as provided in 
section 3 of this act, the following acts are hereby declared 
unlawful. 
(2) (a) To diapense any dangerous drugs unless: 
(b) Such dangerous drug is dispensed by a pharmacist, 
upon a prescription~ and there ia affixed to the immediate 
.• 
container in which such drug is dispensed a label bearing: 
X 
~ (i) The name and address of the phamacy from which 
such drug was dispensed; 
( 11) The name of the pharmacist dispensing the drug; 
(iii) The date on which the prescription for such 
drug waa filled; 
(iv) The number of such prescription as filed in the 
prescription files of the pharmacist who filled such pre-
scription: 
(v) The name of the practitioner who prescribed such 
drug; 
CQNMENTS 
Requirements for labeling 
prescriptions. 
(vi) The name and address of the patient, and, if 
such drug was prescribed for an animal, the name and address 
of the owner and a statement of the species of the animal; 
and 
(vii) The directions for use of the drug as contained 
in the prescription. 
(c) Such dangerous drug is dispensed by a practitioner 
in the course of his practice, and the immediate container 
in which such drug is dispensed bears a label on which ap-
X 
X 
< pears the directions for use of such drug, the name and 
~ 
address of such practitioner, the name and address of the 
patient, the date, and, if such drug is prescribed for an 
animal, the name and address of the owner and a statement of 
the species of the animal. 
(3) To fill or refill any prescription for any danger-
ous drug more than six months after the date on which such 
prescription was issued, and no such prescription which is 
authorized to be refilled may be refilled more than five 
times, except that any prescription for such a drug after 
six months after the date of issue or after being refilled 
five times may be renewed once orally by the practitioner 
issuing it, if such renewal is promptly reduced to writing 
and filed by the pharmacist filling it, and the original 
prescription shall be cancelled. If no indication of refill 
status i .s indicated on the prescription, it shall not be re-
filled. 
(4) To dispense a dangerous drug upon prescription 
x unless the pharmacist who filled such prescription files 
)( 
< ,... and retains it as required in section 4 of this act • .... 
(5) The possession of a dangerous drug by any person, 
unless such person obtains such drug from a pharmacist on 
prescription of a practitioner or in accordance with para-
graph (2) (c) of this section. The possession of any such 
drug which is not in a container labelled in accordance 
with the requirements of subsection (2) of this section shall 
be prima facie evidence that such drug was not lawfully in 
the possession of the person possessing it. 
(6) To manufacture for dispensing any dangerous drug 
CQAMENTS 
without first obtaining a license pursuant to section 6 of 
this act. 
(7) The refusal to make available and to accord full 
opportunity to check any record or file as required by sec-
tion 5 of this act. 
(8) The failure to keep records as required by section 
4 of this act. 
(9) The failure to obtain a license as provided for in 
~ section 6 of this act, or the violation of the terms of any 
< 
such license. 
SECTION 3. Exemptions. (1) (a) The provisions of sub-
sections (1) through (6) of section 2 of this act shall not 
apply to the dispensing of dangerous drugs to persons in-
cluded in any of the classes named in paragraphs (b) through 
(f) of this subsection (1), or to the agents, employees, or 
carriers of such persons, for use in the usual course of 
their business or practice, or in the performance of their 
official duties, as the case may be; or to the possession 
of such drugs by such persons or their agents, employees, 




(b) Pharmacists and practitioners licensed to practice 
or do business in this state; 
(c) Persons who procure such drugs for handling by or 
under the supervision of pharmacists and practitioners em-
ployed by them; 
(d) Hospitals which procure such drugs for lawful ad-
ministration by practitioners; 
(e) Officers or employees of appropriate agencies of 
federal, state, or local governments, pursuant to their of-
ficial duties; 
(f) Licensed manufacturers, wholesalers, clinical re-
searchers, and warehousemen of such drugs. 
(2) All combination drugs enumerated as being exempt 
in the Federal Register, Vol. 32, No. 5, January 10, 1967, pp. 
197-203 and as amended in the Federal Register, Vol. 32, No. 
56, March 23, 1967, pp. 4406-4407, are exempt from the provi-
sions of this act. 
(3) Provisions of subsections (1) through (6) of 
section 2 of this act do not apply to peyote if said drug 
is used in religious ceremonies of any bona fide religious 
organization incorporated under the lan of this state. 
SECTic»l 4. Inspection of stock and records. (1) Any 
dangerous drug in the posseseion of a manufacturer, whole-
saler, carrier, warehouseman, clinical re1earcher, .pharma-




drugs shall, upon the presentation and delivery of written 
request of an inspector or employee duly designated by the 
board or a law enforcement officer of any political subdivi-
sion of this state, and after proper showing of credentials, 
make such files or records available to such officer, inspec-
tor, or employee, at all reasonable hours, for inspection 
or copying, and accord to such officer, inspector, or employee 
full opportunity to check the correctness of such files or 
records. 
SECTION 6. License required - fee. (1) No person 
shall experiment with, study, or test any dangerous drug 
without first obtaining a license as a clinical researcher 
from the board. 
(2) No person knowingly shall produce, or process, or 
manufacture, any dangerous drugs, for sale in this state 
without first obtaining a license as a manufacturer of dan-
gerous drugs from the board. 
(3) No person, except those licensed under subsections 
(1) or (2) of this section, or any practitioner, pharmacist, 
Subsections (1) and (2) of 
section 6 requires clinical 
researchers and manufacturers 
to be licensed by the provi-
sions of this act. 
Subsection (3) of section 6 
requires warehousemen, whole-
salers, and any other person 
X 
X 
X .... .... 
or owner of a pharmacy licensed to practice or do business 
in this state, shall store, possess for dispensing, or other-
wise store or dispense dangerous drugs without first obtain-
ing a license as a dispenser of dangerous drugs or clinical 
researcher from the board. 
(4) All licenses issued pursuant to this section shall 
be for a period of one year from the first day of July and 
may be renewed for a like period annually. The annual li-
cense fee shall be one hundred dollars and shall accompany 
each application for such license or renewal thereof. 
(5) The board shall specify on each such license the 
limitations, if any, of the authority of the licensee there-
under. 
(6) Agents and employees of persons licensed pursuant 
to this section and carriers shall not be required to obtain 
a license under this section. 
SECTION 7. Qualifications for licenses. (l) (a} No 
license shall be issued under the provisions of section 6 
not enumerated in this sub-
section and in subsection 
(6) to obtain a license as a 
dispenser of dangerous drugs. 
Practitioners, pharmacists, 
and owners of pharmacies are 
not required to obtain a li-
cense because they are con-
trolled by the licensing board 
of·their profession. Also 
exempt from licensing are ag-
ents, employees, and carriers 
of drugs of persons licensed 
under this section or by their 
professional boards. 
of this act unless the applicant therefor has furnished proof 
satisfactory to the board that: 
(b) The applicant will produce, process, or manufac-
ture, or will otherwise possess or dispense any dangerous 
drug in the normal course of his business; and 
{c) The applicant is equipped as to land, buildings, 
and paraphernalia properly to carry on the business des-
cribed in his appli~ation. 
(2) (a) Any person licensed as a clinical researcher 
by the federal government shall be presumed to possess the 
qualifications described in subsection (1) of this section 
so long as such federal license is valid. 
{b) A clinical researcher must obtain approval of his 
study, test, or experiment from the state department of 
public health prior to obtaining a license from the board, 
and upon obtaining such approval, the board shall issue a 
license to such clinical researcher. 
(3) (a) No license shall be granted to any person 
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requested, or personal service setting forth the grounds by 
~tatutory reference together with specific allegations of 
fact for the suspension or revocation, and stating that the 
revocation or suspension shall be effective twenty days 
after receipt of the notice, unless prior to that time the 
license holder requests a hearing. 
(2) If the license holder requests a hearing, it shall 
be conducted by the board in accordance with the provisions 
of section 3-16-4, C.R.S. 1963. 
(3) Judicial review of the board's decision may be had 
pursuant to the provisions of section 3-16-5, C.R.S. 1963. 
SECTION 10. Violations - penalties. {l) Any person 
who . manufactures or dispenses dangerous drugs in violation 
of section 2 of this act shall be guilty of a felony, and, 
upon conviction, shall be punished by a fine of not more 
than one thousand dollars and by imprisonment in the state 
penitentiary for a period of not less than one nor more 
than fourteen years. 
Manufacturing or Distribution 
Offenses 
Any person convicted of un-
lawful manufacturing, dispens-
ing, attempting to manufacture 
or dispense, or possess with 
intent to dispense, shall be 
charged with a felony which is 
punishable by imprisonment of 
from one to fourteen years in 
the state penitentiary, and 
fined not more than $1,000 






(2) Any person who attempts to manufacture or dispense 
any dangerous drug in violation of aection 2 of this act 
shall be guilty of a felony, and, upon conviction, shall be 
punished by a fine of not more than one thousand dollars and 
by imprisonment in the state penitentiary for not less than 
one nor more than fourteen years. 
(3) Any person who has in his possession any dangerous 
drug with the intent to dispense said drug in violation of 
the provisions of section 2 of this act, shall be guilty of 
a felony, and, upon conviction, shall be punished by a fine 
of not more than one thousand dollars and by imprisonment 
in the state penitentiary for not l••• than one nor more 
than fourteen years. 
(4) Any person who violates subsections (7), (8), or 
(9) of section 2 of this act shall be guilty of a misde-
meanor, and, upon conviction, shall be punished by a fine of 
not more than five hundred dollars or by imprisonment in the 
county jail for not more than one year, or by both such fine 
and imprisonment. 
Records - Offenses 
Subsection (4) ·states that any 
person can be charged with a 
misdemeanor if that person 
fails to keep records or 
falls to obtain a license un-
der subaection (9) of section 
2. 
Possession Offenses 
There are three penal ties for 
unlawful possession of 
dangerous drugs. The first 
offense is a misdemeanor, and 
the court may sentence the de-
fendant to the county jail for 
· not more than one year, fine 
the defendant not more than 
$~00,or both imprisonment and 
fine. 
In addition, the court can 
grant probation, commit the de-
fendant to the care and custody 
of the department of institu• 
tions for a period of time not 
to exceed one year, or the 
court may defer trial if the 
defendant voluntarily commits 
himself to the care and 
custody of the department of 
institutions. In order to 
have a deferred trial both the 





< .... .... 
I 
(5) (a) Any person who possesses any dangerous drug 
in violation of section 2 (5) of this act shall be guilty 
of a misdemeanor, and upon a first conviction, the court may: 
(b} Impose a fine on the defendant in an amount not 
to exceed five hundred dollars, or a sentence of imprisonment 
in the county jail for not more than one year, or both such 
fine and imprisonment; 
(c) Place the -defendant on probation for a period not 
to exceed one year, and as a condition of such probation the 
court may require the defendant to obtain treatment and re-
habilitation consultation concerning dangerous drugs at a 
community mental health center for such time as a psychia-
trist at the center deems necessary to rehabilitate the de-
fendant; 
(d) Commit the defendant to the custody of the depart-
ment of institutions for a period not to exceed one year, 
for rehabilative treatment. 
(6) {a) At any time prior to trial for a first viola-
tion of subsection (5) of this section or to entry of a 
The second eossession offense 
is also a misdemeanor and the 
court may sentence the defend-
ant not less than one nor more 
than two years in the county 
jail, fine the defendant up to 
$1,000, or both imprisonment 
and fine. 
In addition, the court may 
grant probation or place the 
defendant in the care and 
custody of the department of 
institutions for a period of 
not less than one nor more than 
two years. 
The third possession offense 
is a felony, and the court may 
sentence the defendant to the 
state penitentiary of from one 
to fourteen years, a fine of 
not less than $1,000 or more 
than $2,000, or both fine and 
imprisonment. 
In addition, the court may 
grant probation or commit the 
defendant to the care and 
custody of the department of 
institutions for a period of 
not less than one nor more 
than fourteen years. 
The court may also place con-
ditions on probation which 





I-'• .... .... 
plea of guilty to a violation of said subsection, the court 
may, with the consent of the defendant and the prosecution, 
order the prosecution of the offense be suspended for a 
period not to exceed one year, during which time the court 
may either place the defendant on probation, or, with the 
consent of the defendant, commit him to the custody of the 
department of institutions for rehabilative treatment. 
(b) Upon satisfactory completion of and discharge from 
probation or commitment to the custody of the department of 
institutions, as the case may be, the charge against the 
defendant shall be dismissed with prejudice; but if the 
conditions of probation, or commitment to the custody of the 
department of institutions, are violated, the defendant 
shall be tried for the offense of which he is charged, and, 
upon conviction, the court shall make disposition as pro-
vided in subsection (5) of this section. 
(c) Upon consenting to a suspension of trial as pro-
vided in paragraph (a) of this subsection (6), the defendant 
shall execute a written waiver to his right to a speedy trial. 
CQlRfflUS 
to seek treatment at a com-
munity mental health center 
during the time spent on pro-
bation. 
As indicated in the above 
alternatives, the committee 
was concerned about the possi-
bility of a bill which could 
make young people felons, par-
ticularly if they experiment 
with dangerous drugs one or 
two times. No public good 
would be accomplished by mak-
ing these adolescents felons. 
The purpose of the wide lati-
tude given to the courts is 
to provide education and treat-
ment programs for these young 
people • 
(d) If a defendant gives his consent to a deferred 
prosecution under this subsection (6), it shall not be con-
strued .as an admission of guilt, nor shall such consent be 
admitted in evidence in a trial for the offense of which he 
is charged. 
(7) (a) Whenever any person shall be charged with a 
violation of the provisions of paragraph (5) (a) of this sec-
tion, the court, prior to trial, and with the defendant's 
x consent, shall cause a probation officer to conduct an in-
>< 
)( 
~ vestigation of the background of the defendant which shall 
X 
include, to the extent possible, but not be limited to, such 
information about his characteristics and circumstances af-
fecting his behavior as may be helpful to the court in de-
termining whether prosecution should be deferred under sub-
section (6) of this section, or whether probation should be 
granted if the defendant is adjudged guilty. The court, 
upon its own motion or upon petition of the probation officer, 
may order any defendant who is subject to pretrial investi-
gation to submit to a mental or physical examination, or 
cp,pmn:s 
both. If a mental examination is ordered, the department of 
institutions, upon request of the court or probation officer, 
shall furnish such facilities and services as are necessary 
to conduct such examination. 
(b) Upon completion of such pretrial investigation, 
the probation officer shall submit a written report to the 
court. 
(c) No substantive evidence acquired directly or indi-
rectly for the first time as the result of any such obser-
vation and examination shall be admissible on the issue of 
guilt of the crime charged. 
(8) (a) A person who is convicted of a second offense 
under subsection (5) of this section shall be guilty of a 
misdemeanor, and upon conviction, shall be punished by: 
(b) A fine of not less than five hundred nor more 
than one thousand dollars, or by imprisonment in the county 
jail for not less than one nor more than two years, or by 
both such fine and imprisonment; or 
(c) Commitment to the custody of the department of 
COM'ffli'TS 
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ln.titutiona for a period not less than one YHr nor ac,re 
than two years, for rehabilative treatment; or 
(d) The court may place the defendant on probation for 
a period not to exceed one year, and as a condition of such 
probation the court may require the defendant to obtain 
treatment and rehabilitation consultation at a comaunity 
mental health center for au.ch time as a psychiatrist at the . 
center deems necessary to rehabilitate the defendant. 
(9) (a) A person who is convicted of a third or subae-
,c 
=:: quent offense under subsection (5) of this section shall be 
guilty of a felony, and, upon conviction, shall be punished 
by: 
(b) A fine of not leas than one thousand nor more than 
two thousand dollars, or by imprisonment in the state peni-
tentiary for not less than one nor more than fourteen years, 
or by both such fine and imprisonment; or 
(cl Comi tment to the custody of the department of 
institutions for a period not leas than one year nor mon 
than fourteen yaara, for treatment; or 
(d} It may place the defendant on probation for a 
period not to exceed five years, and as a condition of such 
probation the court may require the defendant to obtain 
treatment and rehabilitation consultation at a community 
mental health center for such time as a psychiatrist at 
the center deems necessary to rehabilitate the defendant. 
SECTION 11. Jurisdiction. Exclusive jurisdiction of 
violations of the provisions of this act is hereby vested 
x in the district courts or juvenile courts of this state. 
I-" ..... .... 
SECTION 12. Commitment to custody of the department 
of institutions - special provisions. (1) (a) After a 
person is committed to the custody of the department of in-
stitutions under the provisions of section 10 of this act, 
but prior to the termination of such commitment, if the 
court which committed such person receives from the depart-
ment of institutions a written statement that such person 
is rehabilitated and that to continue the custody of the 
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(b) Discharge such person from the custody of the de-
partment of institutions; or 
(c) Discharge such person from the custody of the de-
partment of institutions and place him on probation for the 
remainder of the period to which he was originally committed 
to the custody of the department of institutions. 
(2) Except as provided in subsection (6) (b) of section 
10 of this act, if any person committed to the custody of the 
department of institutions under the provisions of this act 
violates any term or provision of such commitment, upon re-
ceipt of notice thereof by the court ordering such commit-
ment, the court may revoke its order of commitment and shall 
sentence the defendant to the county jail or state peniten-
tiary for the remainder of the term of original commitment. 
(3) Any person committed to the department of institu-
tions under the provisions of this act shall have the same 
right to deductions of time as provided in section 105-7-9, 
C.R.S. 1963, and shall be subject to the same forfeitures 
of good time as provided in section 105-7-10, C.R.S. 1963. 
CQM\tENTS 
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SECTICJ4 13. Rule• and regulations. (1) The board is 
hereby authorized to promulgate rules and regulations to im-
plement the prov1sioM of this act. 
(2) The state department of public health is hereby 
authorized to promulgate rules and regulations regarding the 
approval of studies, tests, or experiments submitted by 
clinical researchers for the department's approval. 
SECTI~ 14. Severability clause. If any provision of 
X ..,. this act or the application thereof to any person or circum-.,.. 
< 
l 
stance is held invalid, such invalidity shall not affect 
other provisions or application• of the act which can be 
given effect without the invalid provision or application, 
and to th1$ end the provisions of this act are declared to 
be aeverahle. 
SECTimf 15. Repeal. Arlkl• 4 of Chapter 48. c.a.s. 
1963 1• zepuled. 





to violations of the provisions of the act which occur on or 
after its effective date. 
SECTION 17. Safety clause. The general assembly hereby 
finds, determines, and declares that this act is necessary 





. Much has been written and spoken in recent years about the use 
of drugs in American society. Drug abuse has received attentlon from 
the press, magazines, television, and other communication media. Re-
search reports, numerous conferences and symposiums, and other schol-
•arly activities have been devoted to drug abuse problems. Legislative 
attention has been given to this subject at the federal level, and by 
state and local governments. Public health officials, psychologists, 
psychiatrists, the police, federal officers, ,chool officials, welfare 
personnel! and countless other persons have concentrated a great deal 
of attent on to attempts at controlling drug use. 
This report is not an attempt to cover, or even touch upon, 
all aspects of the problem of narcotics and drug abuse. Instead, the 
purpose of the report is to supplement with some further detail the 
report and recommendations of the Criminal Code Committee with re-
gard to the following seven specific areas: 1) the drugs which are 
abused and their effects on individuals; 2) the extent of drug abuse 
in Colorado; 3) the various treatment programs for drug users which 
are being developed in other parts of the country; 4) information re-
ceived by the committee regarding educational programs for drug con-
trol; 5) the question of whether use of "dangerous" drugs will lead 
to use of narcotic drugs; 6) the relationship between drug use and 
crime; and 7) additional comments by conferees during committee hear-
ings. In addition, an appended item contains a summary df federal 
laws anq laws of other states controlling drugs with a potential for 
abuse • .V 
!/ Information for this report is taken from the following sources: The Challen e of Crime in a Free Societ, a report by the F=e ~i -
ent's commiss on on aw enforcement an administration of jus-
tice (Washington, D.C.: Government Printing Office), 1967, 
(cited as President's Crime Commission): Task Force Report; Nar-
cotics and Drug Abuse, annotations and consultants paper s puS:--
lished by the crime commission (cited as Task Force: Druis); 
Drug Abuse: Escape to Nowhere, a guide fo~ educators (Ph Iadel-
phia: Smith Kline & French Laboratories) , 1967; Dru~ Abuse, 2nd 
ed,, a manual for law enforcement officers, publishe by same 
source; statements presenteo to the Criminal Code Committee hear-
ings on June 2a ~and 29, July 18, and September 7; and information 
presented to the Colorado Drug Abuse Institute, Vail, ColoJ'ado, 
September 12 and 13, 1967, (cited as Criminal Code Committee 
Memorandum No. B). 
Abused Drugs and Their Effects 
Four types of drugs and their effects on individuals are dis-
cussed in this portion of the report -- narcotics (opiates), depres-
sants (sedatives), stimulants, and hallucinogens. In addition, 
solvents and their effects on individuals are mentioned since sol-
_vents can cause physiological and psychological effects in a manner 
similar to drugs. 
Narcotic Drugs 
Narcotic drugs need to be defined both in medical and legal 
terms. A medical definition of a narcotic is any drug that produces 
sleep or stupor and, at the same time, relieves pain. Legally de-
fined, the term means any drug regulated under the federal and state 
narcotic laws, even though some of the regulated drugs are non-
narcotic by medical definition. Drugs classified medically as nar-
cotits include: morphine and codeine (opium derivatives); heroin (a 
morphine derivative); and meperidine and methadone (synthetic mor-
phine-like drugs). All of these drugs have a potential for physical 
and psychological dependence. In addition, the body will develop a 
tolerance for their usage, requiring increased dosages to have the 
desired effects. 
Cocaine and marihuana are two drugs not considered medically 
as narcotics; marlhuana has been classified a mild hallucinogen, and 
cocaine ls considered a strong stimulant. However, these drugs are 
included as narcotics under state narcotic laws, and federal penal-
ties for these drugs are the same as for narcotics. (See Appendix A 
for further information concerning federal law). Present medical 
evidence indicates that users of these drugs probably will not be-
come physically dependent upon either drug. However, some evidence 
indicates that these drugs have a potential for creating psychologi-
cal dependence. 
Narcotic drugs, of course, are the most effective pain reliev-
ers known to medical science. These drugs are quite often adminis-
tered by physicians to patients for short-term acute pain resulting 
from surgery, fractures, and burns, or for relief of pain accompanied 
with the latter stages of terminal illness such as cancer. Morphine 
is a common opiate used in treating pain but many other forms of nar-
cotics, both natural and synthetic, are used for medical purposes. 
The abuse of narcotic drugs lies in the abi li ty of these drugs 
to reduce sensitivity to both psychological and physical stimuli and 
to produce a sens~ of euphoria. Narcotic drugs are depressants to 
the central nervous system, and these drugs can produce drowsiness, 
sleep, and reduction in physical activitr• Under the influenco of 
narcotics, the addict is usually letharg c and indifferent to his en-
vironment and personal situation. Side effects can include nausea 
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and vomiting, constipation, itching, flushing, constriction of the 
pupils of the eyes, and respiratory depression. 
When the narcotic supply is removed from the narcotic addict, 
characteristic withdrawal symptoms develop, which vary according to 
the degree of physical dependence. Symptoms of withdrawal from nar-
cotics mar include: nervousness, anxiety, and sleeplessness; yawn-
ing, runn ng eyes and nose, and sweating; enlargement of the pupils, 
"gooseflesh," and muscle twitching; severe aches of back and legs and 
h-0t and cold flashes; vomiting and diarrhea; increased breathing rate; 
elevation of blood pressure and temperature; and a feeling of despera-
tion and an obsessional desire to secure a dose of narcotics. Th~ 
latter condition is known as the abstinence s,yndrome, which lasts 
longer than any other symptom. 
Depressants 
Depressants are· any of several drugs, including barbiturates · 
which sedate the user by acting on the central nervous system. Medi-
cal uses of these drugs include: treatment of epilepsy, hig~ blood 
pressure, and insomnia; use in the treatment and diagnosis of mental 
disorders; and use in almost any illness or special situation which 
requires sedation. 
Barbiturates are reported to be the most widely used and abused 
of the depressant drugs. Abuse o.f these drugs may lead to physical 
and psychological dependence and a tolerance for the drug. When bar-
biturates are abused, the effects may include drowsiness, staggering, 
and slurred speech, all of which resemble alcohol intoxication. 
Other symptoms of barbiturate addiction may include sluggish reac-
tions, erratic emotions, frequent irritability and antagonism, and 
impressions of euphoria. Death can result from an unintentional 
overdose of barbiturates or from mixing barbiturates with alcohol 
or some other sedating drug which creates a greater effect than 
either drug taken alone (potentiation). Suicidal doses may result 
in a state of general anesthesia. · 
Abrupt withdrawal from barbiturates is extremely dangerous and 
convulsions and dealth can result for a person who is physically ad-
dicted and has developed a high tolerance to the drug. During the 
first eight to twelve hours after the last dose, the addict appears 
to improve but, after this point, the following symptoms may appear: 
increasing nervousness; headache; muscle twitching; tremor; weakness; 
insomnia; nausea; and a sudden drop in blood pressure when the person 
stands abruptly. Convulsions, which may develop after 72 hours of 
withdrawal, is the characteristic which distinguishes barbituric with-
drawal from narcotic withdrawal. 
Stimulants 
Stimulants are drugs which stimulate the central nervous sys-
tom producing excitation, alertness, and wakefulness. Caffeine, found 
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in coffee, tea, cola, and other beverages, is a commonly used stimu-
lant. Amphetamines, sometimes known as "pep pills,• of which there 
are dozens on the market. were reported by the President's Crime Com-
mission to be the most widely used and abused stimulant in the United 
States. As mentioned earlier, cocaine is considered separately from 
the rest of the stimulants because it is controlled under the state 
and federal narcotic laws, whereas other stimulants are regulated by 
dangerous drug or other drug control laws. Cocaine was once widely 
· used as a local anesthetic, but this use of cocaine has been sup~ 
planted by less toxic drugs. Cocaine reportedly is not abused to a 
great extent. 
Stimulants are used medically for treating narcolepsy (a·dis-
ease characterized by involuntary attacks of sleep); counteracting 
the drowsiness caused by sedative drugs; aiding in weight reduction: 
and relieving mild depression. The latter two uses are the main 
medical uses for stimulants. Stimulants may produce a temporary 
rise in blood pressure, palpitations, dry mouth, sweating, headache, 
diarrhea, pallor, and dilation of the pupils. Such effects are gen-
erally seen only with high doses or as side effects with therapeutic 
doses. Stimulant drugs, excluding cocaine, seldom cause death, even 
in acute overdosage. However, delusions or hallucinations may result 
from too large a dose or too sudden an increase in dosage. 
Stimulants are abused because they elevate the mood of the 
user and create a sense of well-being. Most medical authorities are 
reported to agree that stimulants do not create a physical depend-
ence, and there are no physical withdrawal symptoms. Psychological 
dependence does develop, and mental depre·ssion and fatigue are quite 
common after the use of stimulants is discontinued. Psychological 
dependence is an important factor in users• continuance of and re-
lapse to continued stimulant drug abuse. Tolerance also develops in 
use of these drugs. srmptoms of abuse include talkativeness, excita-
bility, restlessness, nsomnia, profuse sweating, urinary frequency, 
and a tremor of the hands. 
Hallucinogens 
Hallucinogenic or psrchedelic drugs are a very broad group of 
drugs which distort percept ons by creating dream images and hallu-
cinations. To date, medical uses for hallucinogenic drugs have not 
been definitely established. Legal possession of hallucinogens is 
strictly controlled by the federal government. The most widely known 
of these drugs include DMT (dimethyltryptamine); LSD (lysergic acid 
diethylamide); mescaline and its salts; and peyote. Provisions of 
the federal law do not apply to peyote use in bona fide religious 
ceremonies of the Native American Church. LSD is considered one of 
the most potent of the hallucinogenic drugs and peyote and mescaline 
are considered moderatelI potent. Marihuana was mentioned earlier as 
being classified medical y as a mild hallucinogen. 
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The general effects of hallucinogenic or psychedelic drugs 
are fairly widely known due to the large measure of interest by the 
public and coverage by the newa media of the "hippie" movement and 
to an apparent increase in the use of mind altering drugs by several 
segments of society. Although hallucinogtnic d:rugs have varying de-
grees of effects which last for varring lengths of time, users have 
reported numerous reactions to LSD ncludlngc visual distortion• of 
.1hape1 and human forms; sharpening of all senses; bright, vivid hal-
lucinations; and depersonalization or loss of ego identity. 
The Medical Society of the County of New York cited the fol-
lowing dangers of LSD uses prolonged paychosia; acting out of char-
acter dl1order1 and homosexual impulses! suicidal inclinations; 
activation of previously latent psychos a; and reappearances of the 
drug'• effects weeks or even lllOnths after use. Corresponding with th••• dangers the same source reported that the LSD user " ••• is·en-
veloped by a sense of isolation and ia often domtnated by feelings of 
paranoia and fear. If large doses are ingested over 700 mcg.) con-
fusion and delirium frequently ensue. During LSD use, repressed 
materlal_~ay be unmasked which is diffucult for the individual to . 
handle."V In addition Dr. Blum told the committee that studies con-
ducted by the National institute of Mental Health have concluded that 
chromos2~e damage has oc.eurred in &ub-human animals given large doses 
of LSD.~ Because of extreme effects which these drugs may have, 
authorities are in agreement that hallucinogenic drugs should not be 
administered other than in a supervised clinical research atmosphere. 
l•rihuana 
This drug is discussed separately from the other major cate-
gories of drugs because of its special characteristics which make it 
difficult to categorize as a narcotic, depressant, stimulant, or hal-
lucinogen. The federal government and all of the states list the 
drug a narcotic drug but the Medical Society of the County of New 
York reported that the drug is a mild hallucinogen. The President's 
Crime Commission said that the effects of the drug are rather compli-
cated, combining both stimulation and depression, with much of the 
drug's effect depending upon the personality of the user.Y 
Marihuana is generally smoked, but the drug can be sniffed or 
ingested. The mental effects of the drug may include a feeling of 
euphoria, exaltation, a dreamy sensation accompanied by a free flow 
of ideas, and a distortion of the sense of time, distance, vision, 
and hearing. Side effects which may accompany these effects include 
res dent's r me Commission, p. 215. 
Criminal Code Commlttee Minutes, July 18, 1967, p. 5. 
President's Crime Commission, p. 213. 
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dizziness! dry mouth, dilated pupils and burning eyes, urinary fre-
quency, d arrhea, nausea, and vomiting, and hunger, particularlr for 
sweets. Much of the effect of the drug depends on the personalty 
of the user. 
Medical science has concluded that marihuana does not produce 
physical dependence and there are no withdrawal symptoms. The use 
.of marihuana may result in a slight psychological dependence in soMe 
individuals. Researchers have compared the effects of marihuana on 
an individual as being similar to the effects of a moderate amount 
of alcohol (also a drug); and, as far as is known, there are few det-
rimental physical effects on the user. 
Since there has been considerable controversy recently con-
cerning the dangers inherent in the use of marihuana, it may be of 
interest to report on statements presented in meetings of the Crimi-
nal Code Committee on this subject. No one who met with the commit-
tee advocated the "legalizing" of marihuana in the sense of the state 
sanctioning its use by removal of all penalties relating to this drug. 
The committee report pointed out that marihuana is still controlled 
br the federal law and state statutes could not be in direct contra-
d ction of the federal statutes concerning marihuana. Further, re-
search at the federal level is reportedly in progress to determine 
more fully the dangers inherent in this drug. This research will' 
undoubtedly take some years to complete. 
In view of the lack of research concerning marihuana, it is 
difficult to state what dangers to society could exist if this drug, 
or other drugs, were legalized. Dr. Richard H. Blum, director of the 
psycho-pharmacology project at Stanford University, told the Criminal 
Code Committee that Morocco is one country where marihuana is legally 
available; consequently, the drug is found in a much stronger form 
than in the United States. It was reported that 18 percent of the 
marihuana users in tb~t country are likely to be hospitalized for 
marihuana psychosis.~ Further discussion of the varified risks and 
reported risks of marihuana is contained in the crime commission Task· 
Force Report: Drugs, pages 24 and 25. · 
Solvents 
The abuse of solvents or "volatile intoxicants" is usually by 
inhalation or sniffing of fumes to produce a form of intoxication. 
Substances abused in this manner include, among other materials, 
glue, gasoline, paint thinne·r, lighter fluid, and ether. Chief dan-
gers of inhaling or sniffing these substances are the possibility of 
death by suffocation, the development of psychotic behavior, and the 
state of intoxication which these substances produce. It is also re-
ported that physical damage to certain body or9ans and to the nervous 
i/ CrlminaI Code Committee Minutes, July 18, 1967, p. 3. 
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system is. a distinct possibility since many solvents and the ingre-_. 
die.,nts of L ,ome types of glue can cause physical damage if taken in- •· 
ternally.w . 
The consultants to the President's Crime Commission cited two 
reasons for concern in the id~ntification of sniffers: 1) to preven\ 
danger while they are intoxicated; and 2) to forestall. the otherwise 
very likely development of later dependency on other drugs and pre-
sumed criminal associations possibly arising out of interest in 
illicit drugs. Two recommendations were submitted by the consultants 
in regard to the identification of sniffers. First would be to en-
courage school and public health persons to develop new methods for 
case finding for children engaged in this activity and, secondly, 
that each school, health, and police agency participate in a com-
munity-wid~1program for the referral of such children to psychiatric 
treatment .11-
Narcotics and Drug Abuse In Colorado 
It is impossible to assess the extent of use of narcotics and 
dangerous drugs in Colorado on the basis of objective statistical 
data. Newspapers, television, and other public media may provide 
some subjective means of measuring the extent of drug abuse, by at 
least indicating through the volume of articles that the drug prob-
lem in Colorado is not insignificant and that the public is inter-
ested in this subject. However, reliable, verifiable statistics on 
the number of drug users, the types and amounts of drugs used, and 
the groups of persons using drugs are simply not available.· 
Statistics from police departments on the number of drug abuse 
arrests may indicate a tremendous percentage increase in police ac-
tivity in drug control in recent years. Such data, however, may be 
indicative of increased police attention to problems relating to drug 
abuse. An increase in percentages may result, in part, from an ex-
tremely low base figure in previous years so that even a few arrests 
for drug abuse would account for a large percentage increase. It is 
possible that, in the case of dangerous drugs, both the most vigorous 
advocates and opponents of drug use tend to exaggerate the extent of 
drug abuse in attempting to prove the validity of their positions 
toward legislation concerning drug use. 
Information received from the regional office of the Federal 
Bureau of Drug Abuse Control, in operation in Denver since mid-1966, 
reported 20 investigations opened for the period of July through 
Y. ~ Abuse: Escape to Nowhere, p. 43 •. y Task Force Report: Drugs, pp. 36-37. (Pap_er by Richard H. Blum, 
assisted by Mary Lou Funkhouser - Balbaky.J 
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September, 1966, while for the same period of 1967, 80 investigations 
were opened on violations of federal dangerous drug laws. No convic-
tions for illegal sale of dangerous drugs were obtained on investiga-
tions conducted by the regional office in 1966, but 18 convictions 
for illegal sale of dangerous drugs were recorded from January through 
September of this year. These convictions were only for illegal sale 
of dangerous drugs and do not include any possession cases, which is 
.not an offense under federal statutes. 
The preceding comments, however, are not intended to dismiss 
the seriousness of drug abuse in Colorado. It is obvious from the 
public media that drugs are being abused and that many segments of 
the public are concerned with problems attendant with drug use. Even 
though complete data, or even reliable estimates, are not available 
on drug use, some generalizations may be made concerning narcotic and 
dangerous drug abuse throughout the United States and in Colorado. 
Narcotics. Taking first the problems of narcotic drugs, this 
area of drug use does not appear to be as severe as the dangerous 
drug problem in Colorado, at least in terms of numbers of users. In 
recent years, the real and absolute numbers of known narcotic addicts 
in Colorado has declined slightly, with the known number of narcotic 
addicts in the state now at 305. However, not all addicts are known 
addicts and it is necessary to multiply the known number by a number 
of from three to ten as an estimate of the actual number. Using 
these figures, the total narcotic addict population would vary be-
tween approximately 900 and 3,050 addicts. 
The President's Crime Commission reported that more than one-
half of the known heroin addicts in the United States are in New York 
and most of the others are in California, Illinois, Michigan, New 
Jersey, Maryland, Pennsylvania, Texas, and the District of Columbia. 
The report stated that, where heroin addiction exists on a large 
scale, it is an urban problem, found largely in areas with low aver-
age incomes, poor housing, and high delinquency. The heroin addict 
was said likely to be male, between the ages of 21 and 30, poorlr 
educated a1_1q unskilled, and a member of a dlsadvantaged ethnic m nor-
ity group.§/ 
Hallucinogens. One of the consultant's papers published in 
Task Force: Drugs reported that the use of hallucinogenic drugs in 
this country appears to be concentrated in young adults age 20 to 25, 
but there are signs of rather rapid diffusion to high school age 
levels and, less rapidly, to middle and older aged adults. ·The same 
authors stated that it would be unwise to venture anI estimate of the 
number of Americans who have tried one or another ha lucinogen; any 
numerical estimates must be suspect. In view of the lack of informa-
tion to the contrary, the following quotation from these consultants 
to the President's Crime Commission, Ythlch concerns the characteris-
JV President's Crime Commission, pp. 212 - 213. 
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tics of LSD users in the United States in general, might be applic-
able to Colorado: 
Until a few years ago, LSD remained limited 
to an "elite" group of successful professionals, 
artists, and comrnuni.cations industry personnel, 
their families and friends. These same groups 
still appear to be using hallucinogens, but the 
concentration of use appears to have shifted to 
younger persons. Among teenagers·, motorcycle club 
members, delinquents, urban poor and minorities, 
etc., there are reports of spreading interest, sug-
gesting the exp.ected diffusion down the socioeconom-
ic scale. No common psychological or sociological 
features may be expected among the users of any 
secular and social drug; different people take drugs 
for different reasons. Within groups sharing common 
sociological characteristics it is sometimes pos-
sible to differentiate drug-interested persons, 
regular users, heavy users, etc., on tb~ basis of 
psychological or background factors ••• .21 
Stimulants, particularly amphetamines, may be subject to abuse 
or non-supervised medical use by persons s.eeking to combat lethargy, 
overweight, and fatigue. Students studying for exams, truck drivers, 
and night shift workers have been cited as groups using amphetamines. 
Social and private use has also been reported for persons seeking 
excitement or mood changes in the sense of "kicks" or "highs". The 
consultants to the Crime Commission reported that various studies 
have identified use among late adolescents, including delinquents, 
but extending to others described as "rebellious," "wild," or simply 
"party going." Some data was reported to support the view that am-
phetamine abusers and those prone to dependency were badlr adjusted 
youngsters before using these drugs.!Q/ A major concern n the con-
trol of stimulant drugs is the vast quantities produced (4~ billion 
tablets in 1962) of which a large percentage,_perhaps one-half of the 
total, is estimated to go into illicit distribution channels. 
Barbiturates. As in the case of stimulants, there is little 
information about which people use barbiturates and how often drugs 
in this classification are used. The extent of abuse of barbiturates 
is difficult to assess, especially since case finding procedures are 
subject to error. One example cited of the problem of identifying 
drug abuse, including barbiturates, was in a Boston hospital in which 
only six of 82 cases of drug abusers had been officially reported to 
an agency.11/ 
y Task Force Report: Drugs, p. 27. (Paper by Blum and Funkhouser -
BaTI>aky.) 
10/ Ibid., pp. 29 - 30. 
II/ I bid ., p .. 34 • 
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In summary, it appears that a changing pattern of drug abuse 
has been evolving in recent years. A large segment of narcotic drug 
abuse historically has been found in ghettos or poverty areas of 
the largest cities in the country. Reasons for this phenomenon are 
many, but one important factor is that the use of narcotic drugs 
represents to the user a form of escape from the realities of a poor 
environment., However, it should be noted that drug abuse occurs in 
all social and economic classes and persons who can purchase their 
drugs without resorting to crime or can afford private treatment are 
less lik~A~ to become a part of police records and drug abuse sta-
tistics.~ 
Dangerous drug abuse, rather than narcotic addiction, is 
often found in the middle- and upper-economic levels of society. 
Perhaps it is because drug problems are no longer limited to cer-
tain geographic areas or to the lower-economic levels, society as a 
whole has become more concerned with problems of drug abuse. Abuse 
of dangerous drugs is said to have a growth pattern starting in old-
er generations and moving down to younger persons, which pattern is 
the reverse of the narcotic addiction pattern. A number of persons 
have said, for example, that abuse of hallucinogenic drugs started 
with college professors and spread to graduate students, then toy~, 
dergraduates, high school students, and even to younger students.~ 
Professor Blum told the Committee that the group of LSD users is be-
coming younger, even to the extent of e14~entary school children in California experimenting with the drug • .:!:!V Corresponding with the 
shifting pattern of drug abuse to include middle- and upper-economic 
and social levels of society, Professor Blum stated that the younger 
generation's drug abuse has shifted away from alcohol, narcotics, 
and other toxic substances to more sophisticateg_qrugs, including 
LSD, marihuana, and other exotic hallucinogens.12/ 
It is also pointed out that young people are not the only 
drug abusers as many respectable adults in all occupations abuse 
drugs. For example, physicians and others who have irregular sleep-
ing habits and need to sleep immediately after lying down, may have 
a tendency to abuse depressant drugs. Drug abuse by young persons 
may be in the form of experimentation and by persons who want to ex-
plore life of which drug use is just one aspect. Seldom do young 
people continue drug abuse. Adolescents who continue using halluci-
nogenic 9f~gs are said to do so because of some deep-rooted emotional 
problem.!21 
2 Dry9 Abuse, p. 15. 
TI/ Criminal Code Committee Minutes, June 28 and 29, 1967, p. 36. 
B/ Ibid., July 1e, p. 2. 
15/ Ibid., p. 4. I§/ Ibid., June 28 and 29, pp. 33 - 34. (Statement by Dr. L. Barbato, 
Student Health Services, Denver University.) 
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Drug Treatment Programs 
When considering the development of treatment programs for 
drug abusers and addicts, the distit;1ctions between "dangerous drugs" 
-- hallucinogens, stimulants, and depressants -- and "hard narco-
tics" become somewhat complicated. For example! use of practically 
.any drug or substance can create a psychologica dependence for the 
user, but a physical dependence is generally consideted to develop 
only in use of narcotics and depressants. However, the committee 
was told that psychological dependence was much more difficult to 
cure than was physical withdrawal. Further, physical withdrawal from 
barbiturates and other sedatives (depressant drugs) pose serious dif-
ficulties which can require more intensive medical supervision than 
does withdrawal from opiates. Deaths can occur if dependence tp 
these drugs is not detected and convulsions and delirium occur • .!1/ 
In short, it appears that a variety of treatment approaches 
and facilities would be required to handle the different types of 
drug abusers. Chronic abusers of hallucinogens, stimulants, or sol-
vents might need to be treated for emotional or psychological prob-
lems rather than physical withdrawal. Abusers of depressant drugs 
appear to need trained personnel and intensive care facilities during 
the withdrawal stage from drugs followed by psychological counseling 
programs. A program for narcotic addicts, in order to have a chance 
for 5uccess, requires withdrawal facilities, psychiatric services, 
and aftercare programs to assist in the addicts' return to the com-
munity. 
Policy questions concerning treatment programs which need to 
be answered include whether a treatment program is needed for users 
of all drugs, including hard narcotics and the dangerous drugs, or 
should attention be focused on treatment programs for selected 
drugs? Does the number of narcotic drug users in Colorado warrant 
the development of a treatment center by the state? If persons use 
some of the non-narcotic drugs on themselves, without noticeable 
harm to society, should the state use its resources for a problem 
which mar be considered more troublesome by the general public than 
it actua ly is, medically speaking? 
As far specific needs for treatment facilities in Colorado, 
the following excerpt of the statement presented to the committee by 
Dr. Hans Schapire, Chief of Psychiatric Services of the Colorado De-
partment of Institutions, represents the viewpoint of one person who 
is familiar with the state's existing facilities and with probable 
future needs for a narcotic treatment program: 
lz7 Task Force Re1ort: Drugs, p. 142. (Paper by Jonathan o. Cole, M":D., Nationa Institute of Mental Health.) 
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As you undoubtedly know, the two federal 
narcotic hospitals at Lexington, Kentucky,and 
Fort Worth, Texas,are in the process of being 
converted into pure research facilities. This 
means that narcotic addicts from the various 
states will no longer be able to receive treat-
ment in these two facilities which have been 
placed under the jurisdiction of the National 
Institute of Mental Health. The intent of Con-
gress as spelled out in the Narcotic Addiction 
Rehabilitation Act of 1966 (Public Law 89-793) 
is the provision of treatment and rehabilitation 
facilities for the narcotic addict in his own 
state or community. For this purpose, the Sur-
geon General has been authorized to make such 
contractual arrangements as may be necessary 
with private and public facilities to provide 
examination and treatment for persons falling 
under the provisions of this act. It seems 
therefore highly desirable that both the State 
Hospital and the Fort Logan Mental Health Cen-
ter be prepared to treat addiction and habitua-
tion so that the most appropriate treatment for 
the individual be available both on an inpatient 
and ambulatory basis. As far as Colorado State 
Hospital is concerned it has now in operation an 
alcoholic treatment and addiction center housing 
about 70 patients. The overwhelming majority of 
these persons are alcoholics. It would not be 
too difficult to expand existing services and to 
provide more specialized services for those nar-
cotic addicts who will require care no longer 
available in the Federal centers. However, 60% 
of the known addicts in Colorado {total number 
200) live in the Denver metropolitan area. I 
therefore recommend that a specialized treatment 
unit be developed at the Fort Logan Mental Health 
Center, staffed by those interested and skilled 
in the treatment of drug dependence. This new 
unit should probably be a part of a new division 
which would include the present alcoholism unit. 
A careful study would have to be undertaken to 
determine what, if any, additional construction 
will be required. However, legislative intent 
and concern should be expressed by making plan-
ning funds available to the Department of In-
stitutions in the next session of the General 
Assembly. 
Even the most modern treatment facility and 
the most dedicated staff will have poor results 
unless provisions are made to carry the rehabili-
tation of the narcotic addict into the community. 
-13-
It might be wise in the course of.funded plan-
ning to learn more about the operations and 
experiences of the California rehabilitation· 
center, the program of the State of New York, 
and about certain.J:)f.}W methods of treatment of 
narcotic addicts.!!!/ 
It will be noted that practically all of the treatment pro-
grams concern treatment for narcotic addicts, particularly for her-
oin users. Estimates of Colorado narcotic addicts vary between 900 
and 3,000 persons. A more serious problem, in the number of abusers, 
probably exists in regard to dangerous drug users. · 
For drugs which are physically addicting, reports indicate 
.that some experimental programs have been more successful than pre-
vious programs, which have detoxified the addictt but returned him 
to his old environment. Generally, more successtul treatment pro-
grams consist of controlled withdrawal in a hospital setting, re-
habilitation programs, and aftercare treatment. The basic elements 
of a program developed by the Boston state hospital may be of in-
terest in illustrating one program developfg,for narcotic and bar-
bituric drug users by a state institution.!zt 
It is interesting to note that most of the patients admitted 
to this program were said to have severe character disorders for 
which they need assistance nearly as much as for their drug addic-
tion problem. Prior to their admittance to the program, the patients 
were reported to have averaged three arrests, usually for crimes com-
mitted to procure drugs. The patients represented a wide variety of 
work experiences but are below average in work skills and abilities. 
The educational level of the addicts was said to range widely, with 
as low as the third grade level and a median at the tenth grade 
level. 
When the addict is first admitted, he is examined physically, 
and a drug withdrawal program is initiated. If the addict uses nar-
cotics, methadone, a synthetic narcotic drug, is used for about four 
weeks in decreasing quantities during withdrawal. If the addict has 
a barbital dependence, nembutal is administered in decreasing quan-
tities during withdrawal, for approximately six weeks. If after a 
reasonable length of time an addict cannot be withdrawn under this 
treatment method, he is referred elsewhere. 
Use of drugs during the withdrawal phase was described as an 
adjunct to other forms of treatment. For example, during and after 
l§/ Criminal Code Committee Minutes, June 28 and 29, pp. 20 - 21. 
I2,/ Criminal Code Committee, Memorandum No. 8, pp. 2-3. (Notes on 
treatment program by Dr. David J. Myerson, Psychiatrist, Boston 
State Hospital.) 
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withdrawal, the addict begins to develop a few basic work habits by 
assignment to the shop area. An addict may feel depressed and there 
may be a considerable disparity between his aspirations and his ac-
tual work level. 
After withdrawal is completed, the patient is given a series 
of tests to determine whether he should return to school for further 
education or should be sent directly into the job placement program. 
The treatment program maintains a job placement file and jobs are 
found for the addict. The center tries to scale the addict's em-
ployment to realistic work standards that off er reaso'nable chances 
of success. At this point in the program the hospital ward becomes 
a half-way house with the addict going to school or his job during 
the day, and returning to the ward at night. Group therapy sessions 
are held in the evenings in which the addicts can discuss problems. 
These group therapy sessions were said to provide a safety valve for 
release of the addict's daily problems. 
When the addict is fully employed and has developed some 
basic work habits, he is released to an out-patient status and the 
aftercare program begins. The aftercare program is concerned with 
physical and mental problems and consists of frequent visit~, health 
care, and readjustm~nt to family life and society. Studies have 
concluded that a drug addict abuses his health and continues to neg-
lect his health for a long period of time after withdrawal. The 
family life generally lacks love and other family problems may be 
present. Frequently, the spouse of the ex-addict treats him as if 
he was still addicted to drugs. The program provides family rela-
tion services and may bring in other social agencies in an attempt 
to bring the family closer together. If at any time there is evi-
dence that the ex-addict is using drugs, he is readmitted to the 
ward. 
Several other experimental programs have been initiated in 
an effort to find better or more permanent treatment progr~ro~ for 
drug abusers. Some of these programs are mentioned below.~ 
(1) Methadone maintenance is a program of substituting metha-
done for heroin. The program was started in New York by Drs. Vincent 
P. Dole and Marie Nyswander. In this program the addict is withdrawn 
from heroin and gradually methadone is administered until a daily 
dose is stabilized. The effect of methadone is to block the euphoric 
effects of heroin and methadone does not produce euphoria sedation or 
distortion of behavior. The addict returns daily to the clinic for a 
dose of methadone. Tests are made for the presence of heroint and if 
a test is positive (i.e., heroin found in the addict's system,, he is 
removed from the program. No meaningful conclusions have been made 
W' Ibid., pp. 7-8. (Notes from Dr. Patrick Hughes, National In-
stitute of Mental Health. See also, President's Crime Commis-
sion Report, pp. 225 - 228.) 
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from the prog~am because of the newness of the program. Patients 
in the hospital ln which this program has been used and school drop-
outs in slum areas are said to be enthusiastic about the possibili-
ties of this approach. The crime commission reported that the 
results of research on this subject are fragmentary and final judg-
ments on its suitability are not yet possible. 
(2) Ha\fwa~ Houses. Several communities have established 
·helfway houses. Te houses frequently will have ex-addicts on the 
sta·f.·f .for liaison and orderly duties. Group therapy and guidance 
will be major functions of the house. An attempt will be made to 
change the addict's environment. No pressure is made to have the 
addict obtain a job immediately upon joining the house, although 
the persons in the house are expected to assume responsibilities 
for the house while living there. . 
(3) Hai~ht-Ashbur1 Medical Clinic was recently established by th~ Universl y of Call ornla Medical School. The clinic is open 
to treat any hippie who wants medical treatment for social and other 
diseases as well as for "bad trips" on LSD. This program is too new 
to formulate any conclusions concerning appropriate treatment for 
LSD users. However, one consultant to the President's Crime Commis-
sion indicated that abusers of LSD and other hallucinogena who 
develop psychiatric symptoms .(sc.hizophrenic-like or panic reactions) 
can probably be adequately handled in conventional psychiatric set-
ting!$. 
(4) Community Addiction Centers have been established in 
store fronts In a few large cities. One major purpose of these 
centers is to dispel the commonly held belief that drug addicts 
cannot be treated. Ex-addicts have been working in these centers 
and block workers, including VISTA members apd local residents, co-
operate in educational programs concerning drugs for the particular 
block or area. · 
As for treatment for abusers of stimulant and depressant 
drugs, it has been suggested that some combination of intensive 
supervision and treatment plus regular monitoring to detect relapse 
might be useful. However, the same source stated .that more study 
of the groups abusing these drugs is needed urgently as a basis for 
clearer recommendations. It will be recalled that withdrawal from 
depressants may require more intensive medical supervision than does 
withdrawal from "hard" narcotics. Thus, some specialized training 
may be necessary for personnel in institutions which might handle 
cases of depressant drug abuse. 
It should be pointed out that in treatment programs developed 
thus far for depressant drug abusers, the prognosis for cure of 
physical dependence is poor, and the problems presented are reported 
to be similar to problems encountered in the treatment of opiate ad-
dicts. However, a strong argument can be made for an effort in the 
direction of treatment programs rather than taking a punitive ap-
proach toward these drugs. One of the ~onsultants of the crime com-
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mission report compared a punitive approach for depressants with the 
futility of that approach for alcoholic and narcotic addicts. 
While little is known about punitive ap-
proach toward users of "medical depressant or 
stimulant drugs," it may be expected that as in 
the case of alcoholics and narcotic addicts a 
punitive approach to users who have lost control 
over their use will result in a "revolving door" 
or a repetitive cycle of arrest, release and 
arrest, or arrest, conviction, imprisonment, re-
lease and arrest. In neither the case of the 
alcoholics nor narcotic addicts has it been 
shown that such a process aids the user to aban-
don his habit. The only thing that such a 
process accomplishes is to keep dependent users 
off the streets for some period of time. In the 
case of alcoholism it has been referred to as 
"life imprisonment on the installment plan." If 
the sole object of this process is to keep de-
pendent users off the streets, the object could 
be better accomplished either by longer prison 
terms or by long periods of nonpunitive isolation 
from society. 
Isolation would be based on the view that 
addicts and habitual users commit crimes and 
sell drugs to support their habits, or for other 
reasons, and introduce nonaddicts to drugs. 
This view has been advanced to support long peri-
ods of isolation for narcotics and addicts irre-
spective of whether a particular addict has 
committed a crime other than possession or use ••• 
The known facts certainly do not warrant it in 
the case of addicts and habitual users of "medi-
cally depressant and stimulant drugs •••• " 
If it is feared that dangerous drug abusers 
will introduce nonusers to drugs and distribute 
drugs, they may be punished for trafficking 
offenses including possession for the purpose of 
sale or distribution. If it is feared that use 
will lead to crime, the user may, unless he 
should be determined irresponsible, be punished 
for the crimes he commits. If particular 
abusers are dangerous to themselves or others 
because of mental illness or otherwise meet 
general requirements for hospitalization of the 
mentally ill, they should be treated as other 
mentally ill persons and isolated for the safety 
of society and of themselves and for any pos-
sible treatment that may be afforded to them. 
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If they only possess or use drugs and are not 
sufficiently disturbed by their use to meet us-
ual standards for commitment as mentally ill, 
or as long as there is little likelihood that 
they can be successfully treated, they should 
not be subjected to nonpunitive isolation ••• l!/ 
Drug Education Program§ 
Several criticisms of present drug education programs were 
mentioned to the Criminal Code Committee. The educational issues 
raised might best be summarized in the questions: Who needs to be 
educated in regard to drug abuse? How can the most beneficial edu-
cational programs be developed? 
Professor Blum and several other conferees told the committee 
that, in general, the best approach to the drug abuse problem wtls 
through education. It is necessary to teach youths that, if it is 
necessary to explore, it is important to have the proper education 
to explore. Attitudes toward drugs should be formed early, begin-
ning in the elementary schools. Parents should begin teaching 
children informally the dangers of drug abuse. Dr. Blum said that 
adolescents should have a basic grounding of drug education by age 
fourteen. 
An educational approach toward drugs requires that teachers 
be well educated on drug problems before they begin to teach stu-
dents. One problem mentioned in regard to some educational ·programs 
was that the students will known more about drugs than do the teach-
ers. The crime commission verified previous conclusions that public 
and professional education in the field was inadequate and was 
"clouded by misconceptions and distorted by persistent fallacies." 
Professor Blum stated that many educational attempts were archaic 
with the proper methods and aids simply not available to teachers. 
It was also noted by Dr. Blum that parents, the police, and 
medical doctors need to be included in the drug education program 
since these persons are in a position of influencing patterns of 
drug use in the society. One specific suggestion was that state 
funds be made available~iq educate law enforcement officers in drug 
abuse and drug control.~ 
W Task Force Report: Drugs, pp. 104 - 105. (Paper by Michael P. 
Rosenthal, Associate Professor of Law, Rutgers, the State Uni-
versity, School of Law, Camden, New Jersey.) 
22:f Criminal Code Committee Minutes, July 18, pp. 4, 10. 
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A staff member of the state department of public health sug-
gested that an educational program include the teaching of safe use 
of prescribed drugs which are used in every day medicine, many of 
which are extremely potent. This topic should be interwoven into 
the health curriculum of the schools so that future citizens have a 
complete understanding of both the dangers and benefits of modern 
drugs. It was reported that the Colorado Public Health Association 
is develgp~ng a project to formulate curriculum material on this 
subject.W 
The possibility of children experimenting with drugs at an 
earlier age, because of their knowing about drugs, was acknowledged 
by Dr. Blum as a possible danger of a drug education program. How-
ever, this remark was qualified by the statement that children are 
going to hear about dangerous drugs sooner or later, and it will be 
better for the children to have a well-rounded drug education which 
would provide an intelligent choice on whether to experiment with 
dangerous drugs. If the children are inclined to experiment, at 
lea~t th?Y w~!l have knowledge of the drugs with which they are ex-
perimenting.~ 
It may be easier to cite the need for increased educa.tional 
efforts in regard to drug abuse than it is to present a workable 
program tnrough which young persons can be accurately and adequately 
informed on the dangers of drug abuse. A sound drug education for 
teachers in elementary grades, as well as in junior high and high 
schools, appears to be one of the first necessary steps. Use of 
technically qualified professional persons, including medical doc-
tors and pharmacists, by the schools in developing drug educational 
programs could be highly significant. Some educational materials 
can be obtained from pharmaceutical manufacturers, federal offices, 
and from film libraries. In view of criticisms discussed earlier 
of some of the teaching materials that are being used, it is impor-
tant to carefully evaluate the drug education information being 
presented in the schools. 
The Question of Dangerous Drugs 
Progressing to Use of Narcotic Drugs 
Another consideration to be noted concerns the possible pro-
gression of drug use from dangerous drugs to hard narcotics. There 
are some popular beliefs that a correlation exists between marihuana 
use and later addiction to heroin. Similar beliefs might be held in 
regard to use of other dangerous drugs and the future use of "hard" 
W Criminal Code Committee Minutes, June 28 and 29, p. 59. 
W Ibid., July 18, p. 12. 
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narcotics. Dr. Blum reported to the President'e Crime Commission 
that"The evidenc& from college students and utopiate and news arti-
cles is clear that many persons not in heroln•risk neighborhoods,~~<} 
experiment with marihuana do not 'progress' to 'hard' narcotica."~ 
In another paper to the Commission Dr. Blum stated: 
Most persons who experiment with marihuana do 
not try heroin, some heroin users •• • even in . 
slum cultures ••• have not first tried marih'uana, 
and among heroin users first trying marihuana 
a number of other common factors are also 
likely to be present. Among these may be ex-
perimentation with other· illicit drugs reflec-
ting a general,Battern of drug interest and 
availability.l2/ · 
Dr. Alan Frank, a psychiatrist at the UniverEitr of Colorado 
Student Health Services, in speaking of LSD use, expla ned that cer• 
tain people need a crutch throughout life and will search until they 
find their crutch. Drugs, to many persons, represent a crutth. If 
one of the milder drugs does not give the desired effect, an indl-
viduat.,ill search for a stronger drug to obtain the necessary sup-
port.~ Taking this view, it could be concluded that the p~~sonality 
makeup of these persons, rather than the use of milder drugs, could 
push these persons into the use of narcotics. 
Dr. Blum also stated to the committee that the best theory on 
drug addiction assumes that a certain pre-mental pattern must be pre-
sent before a person will become addicted to drugs. Also, the use 
of drugs over a long period of time was said to increase tha chances 
for drug addiction. This latter theorr on drugs was eompared ~Bth a 
similar pattern found in use of alcoho leading to alcohol1$m.i£' 
Drµg Use and C:rime 
Another important question on which there has been considerable 
discussion over a long period of time concerns the possible correla-
tion between drug use and crime. The President's Crime Commission 
and the consultant's papers provided considerable discussion to the 
question of a possible relationship between drug abuse and crime. · 
This subject is complicated by a lack of adeqUate evidence! partic-
ularly in regard to use of marihuana end crime. Any rel1t1onship 
between crimes and drugs appears to depend upon such factors as the 
W Task Force: Drugs, p. 24. (Paper by Blum and Funkhouser• 
Balbaky}. 
w_ Ibid., p. 53. (Paper by Blum and Braunstein). 
w_ Criminal Code Committee Minute§. June 28 and 29, p. 39. 
l§/ Ibid., July 18, p. 3. 
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personality of the individual using the drug, the drug being used, 
· and the person's style of life before and after using the drugs. In 
discussions of this topic it is advisable to consider the users of 
hard narcotics separately from the users of certain dangerous drugs. 
Two reasons were pointed out whereby persons who are addicted 
to hard narcotics are not able to maintain their addiction without 
running afoul of the criminal law. First, an addict has a constant 
need for drugs which must be purchased and possessed before they 
can be consumed. Purchase, possession, and sale of opiates, in gen-
eral, are criminal offenses under state and federal laws. The com-
mission also noted that many states have prohibitions against the 
possession of paraphernalia, such as needles and syringes, designed 
for use by narcotic addicts. Thus, the commission concluded, the 
narcotic addict lives in almost perpetual violation of one or sev-
eral criminal laws which pertain directly to the use of drugs. 
The second conflicting area concerns offenses of the fund-
raising variety. Assaultive or violent acts, contrary to popular 
belief, were said to be the exception rather than the rule for the 
heroin addict, since the drug has a calming and depressant effect. 
However, in order to support the narcotic habit, the addict must 
usually turn to crime, particularly the theft of property. 
The following statistics used by the President's Crime Commis-
sion were supplied by the Federal Bureau of Investigation. A total 
of 4,385 people identified as heroin users had an average criminal 
career (the span of years between the first arrest and last arrest) 
of twelve years during which they had averaged ten arrests. Six of 
these arrests, on an average, were for offenses other than narcot-
ics.12/ Dr. Blum pointed out to the committee that many narcotic 
addicts had criminal records before they became addicted to narcot-
ics. They show trends of continued use of narcotics and they will 
also continue criminal activities.~ 
In regard to a correlation between crime and violence and 
use of marihuana, the President's Crime Commission said that dif-
ferences of opinion are absolute and the claims are beyond reconcili-
ation. One view is that marihuana is a major cause of crime and 
violence and another is that marihuana has no association with crime 
and only a marginal relation to violence. In essence, the Commis-
sion reported that neither side could prove their case based on 
present evidence but suggested the following hypothesis in regard 
to crime and violence occurring with the use of marihuana: 
W. President's Crime Commission, pp. 221 - 222. 
~ Criminal Code Committee Minutes, July 18, p. 7. 
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One likely hypothesis is that. given the 
accepted tendency of marihuana to release in-
hibitions, the effect of the drug will depend 
on the individual and the circumstances. It 
might, but certainly will not necessarily or 
inevitably, lead to aggressive behavior or 
crime. The response will depend more on the 
individual than the drug. This hypothesis is 
consistent with the eviden~e that marihuana 
d~es not alter the basic personality struc-
ture.W 
In discussing drug use and. crime with the committee, Dr. Blum 
mentioned that the hallucinogens may cause the user to engage in 
some bizarre acts and also have caused some suicides. Statistics on 
amphetamine use were said to show no causal relationship between the 
drug and crime. Cocaine was reported to show some evidence of caus-
ing agitation, but the direct relationship of the drug to crime was 
remote. It is interesting to note that Dr. Blum said that one known 
causal relationship between drug use and crime was with alcohol. 
Crimes committed under the influence of alcohol were described as 
crimes of violence, although studies on this subject have shown that 
the person committing such an act and the person against whom the 
act was c~~itted have had previous histories of committing acts of 
violence.~ 
Possibly the best summary of the question of a relationship 
of drug use to crime is the following quotation from Dr. Blum in a 
paper to the President's Crime Commission: 
••• LI7he.best evidence to date suggest that 
the drug-crime relationship depends upon the 
kinds of persons who choose to use drugs, the 
kinds of persons one meets as a drug user, and 
on the life circumstances both before drug use 
and those developing afterward by virtue of the 
individual's own (e.q., dependent or addictive) 
response and societyis response to him (prohibi-
tion of use, arrest, and incarceration, etc.). 
In spite of popular beliefs.to the contrary, one 
dare not assume that drug-dependency qua dependen-
cy leads inevitably to any particular type ~f 
social conduct, including criminality. Insofar 
as some activities are part of obtaining and us-
ing the drugs themselves, these will be repeated 
225. 
July 18, pp. 7-8. 
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but these activities may or may not be criminal 
depending, as we have noted, on the laws and 
social circumstance of the person.W 
Additional Statement§ to the Committee 
In addition to the material previously included in the Com-
mittee Report and Recommendations and in the Background Report, a 
number of other statements were submitted and considerable discus-
sion was held with the conferees who met with the committee on June 
28 and 29, July 18, and September 7. Copies of the complete state-
ments and the discussions with these conferees are available in the 
committee minutes. However, in order to provide a more complete 
picture of the variety of points of view expressed in these hearings 
and to mention some additional issues presented to the committee, a 
brief outline of the statements of four conferees is presented below. 
Mr. John Gra Detective Intelli ence and Narcotics Bureau 
Denver Po ce Department. De ec ve rays pos tion,on anger-
ous drugs was to favor stringent legislation controlling all'danger-
ous drugs because the drug abuse problem in Colorado has grown to 
large proportions in recent years. The problem was due primarily to 
an influx of "hippie type subcultures.• This influx is due to a 
lack of state legislation controlling dangerous drugs. Strong lawa 
concerning dangerous drugs would discourage hippies from coming to 
Colorado for they would know they would be dealt with firmly if they 
did enter the atate. . 
For adequate control of the drug abuse problem, the police 
departments in Colorado need strong penalties for unlawful posses-
sion and use of the dangerous drugs. It is difficult and expensive 
to control dangerous drug abuse without possession penalties because 
of the difficulty of proving unlawful sale. Undercover agents buy-
ing unlawfully possessed drugs must be specially trained, and they 
can be used as an undercover agent only once in any one area. With 
strong possession and use penalties, it would be unnecessary to 
prove unlawful sale, and undercover agents would not have to be 
used. Detective Gray said that a weakness of the federal law is 
that it fails to make possession and use of dangerous drugs illegal. 
@ Task Force: Drugs, p. 23. (Paper by Blum and Funkhouser -
Balbaky). 
W Criminal Code Committee Minutes, June 28 and 29, 1967, pp. 
42 - 46. 
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Mr. Lester Thomas, Denver Juvenile Court.~ Mr. Thomas has 
worked primarily In the area of solvent abuse. He was opposed to 
any state legislation which would make solvent abuse a crime and 
suggested two reasons why solvent abuse should not be a crime. 
First, any attempt to control all solvents would fail because of the 
wide use of solvents which can be abused. 
Second, the only solvent abuser who would be prosecuted would 
be those children who are from the lower income families who have 
serious family, economic, and social problems with which they must 
cope. Making these children delinquents or attaching a stigma of 
glue sniffer would only cause greater problems for the child. Mr. 
Thomas said that children who sniffed glue alone, away from his 
peers, needs psychiatric help and education, and therapy is need,d 
for the whole family. . 
Mr. Jose h Arnold d 
Church o Chr st. r. rno e a e comm ee a no 
heard from enough disciplines concerned with drug use to develop a 
comprehensive idea on a total drug legislation program. The commit-
tee should listen to authorities from certain religious elements, 
artists, and the intellectual element of society, Mr. Arnold· said. 
Each of these groups claim that use of hallucinogenic drugs bene-
fits thei~ group in some way, and these people should be given a 
chance to explain their point of view and to prove their claims 
about drug use. 
From a personal view, Mr. Arnold favored drug legislation 
along the lines adopted by the federal government with penalties for 
illegal sale, distribution, and manufacture of drugs. He pointed 
out that young people should not be made felons because of their 
experimenting mind. Mr. Arnold urged the committee not to be pushed 
into hasty drug legislation by public pressure since the lives af-
fected most by drug legislation are adolescents. 
Dr. Alan Frank Ps chiatrist Stude t Healt Servic s 
versity of Colorado. Dr. Fran spo e tote comm ttee as a 
psychiatrist, not as a member of the University staff. The drug 
abuse problem was said to be impossible to solve. The use of dan-
gerous drugs is basically a moral issue or conflict between gener-
ations. Legislators have to separate moral attitudes from objecti-
vity in reaching a decision on the use of drugs. The older elements 
of society generally reject drug abuse, and the younger generation 
is more willing to experiment with new ideas. Dr. Frank pointed out 
that use of alcohol, tobacco, and coffee were capital crimes in 
various parts of the world during the 18th Century. The question 
35 Ibid., pp. 39 - 41. 
W. Ibid., September 7, 1967, pp. l - 6. 
W Ibid., June 28 and 29, 1967, pp. 36 - 39. 
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to be answered before legislation 1s passed is where do these drugs 
fit into society. 
Dr. Frank said that while he did not advocate use of danger-
ous drugs, he was opposed to severe possession penalties. Drug 
legislation should be concerned with the sources of dangerous drugs. 
The best approach to the LSD problem was through education, 
Dr. Frank stated. Explain all aspects of LSD in terms adolescents 
can understand; talking in adult terms gives young people the im-
pression that what is said about LSD is adult propaganda. If ado-
lescents are given the proper education, at least they will be able 
to make an intelligent decision on whether or not to take LSD when 
they are confronted with the situation. 
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APPENDIX A 
COMPILATION OF FEDERAL LAWS 
REGARDING NARCOTICS AND DRUGS 
Harrison Narcotic Act. Termed the first effective narcotics 
control measure, this law initiated a policy which is still the 
basis of present drug control programs. Enacted as a revenue 
measure, the Treasury Department is designated as the enforcement 
agency. 
As a revenue measure, the Harrison Act imposes a tax of one 
cent per ounce on narcotic drugs produced or imported in the United 
States and sold or removed from consumption or sale. The tax is 
imposed upon the following narcotic drugs: opium, isonipecaine, 
coca leaves and opiates; compounds, manufactures, salts, derivatives, 
or preparations of the foregoing; and substances chemically identical 
to the foregoing. 
Payment of the tax must be evidenced by stamps affixed to the 
package or container. No person may purchase, sell or distribute 
narcotic drugs unless he does so from a stamped package. Possession 
of narcotics in unstamped containers is "prima facie evidence of a 
violation." 
The act allows•the Secretary of the Treasury to determine 
whether a pharmaceutical preparation containing a narcotic drug 
combined with other ingredients should warrant application of the 
law. Except for the dispensing of narcotic drugs to a patient by 
a practitioner "in the course of his professional practice only" 
and the sale, dispensing, or distribution of narcotic drugs by a 
dealer to a consumer in pursuance of a practioner's prescription, 
sale or transfer of narcotic drugs is unlawful except in pursuance 
of a written order or a recipient on an official form supplied by 
the Treasury Depar\ment. 
Persons in the vocation involving the handling of narcotic 
drugs must register annually with the Treasury Department and pay 
an occupational tax graduated from one dollar to 24 dollars per 
year. They are also required to keep records, make them available 
to law officers, and file returns as required by the Secretary of 
the Treasury. 
Traffic in narcotic drugs without registration is a separate 
offense, independent of failure to register. Thus, the transpor-
tation of narcotic drugs in interstate commerce by persons not 
registered is prohibited except for employees and agents of regis-
trants within the scope of their employment or other authorized 
persons within the scope of their employment. 
-27-
marihuana, morphine, opium, paraldehyde, ~eyote, or suphonmethane-
or chemical derivatives of the foregoing. 
2) Prescription is required for the dispensing of a drug 
intended for use by man whichi 
(a) contains certain narcotic and other sub-
stances or substances designated by regula-
tion as "habit forming," 
(b) is not safe except under the supervision 
of a licensed practitioner because of its 
potentiality for harmful use, or 
(c) is limited to use under the professional 
supervision of a licensed practitioner under 
procedures for the introduction of new drugs 
into interstate commerce. 
3) No new drugs may be introduced into interstate commerce 
unless an application filed with the Secretary of Health, Education 
and Welfare is in effect with respect to such drug. 
4) Annual registration is required of establishments that 
manufacture, c6mpound, or process drugs and that wholesale or 
distribute any depressant or stimulant drug. The 1962 Drug Act 
established registration requirements. The depressant and stimulant 
drug registrations were added by the Drug Abuse Control Amendments 
of 1965 which established special federal control~ over depressant, 
stimulant, and hallucinogenic drugs. 
Section 301 of the Federal Food, Drug and Cosmetic Act, as 
amended in 1962 and 1965, enumerates prohibited acts as followsi 
(a) Introduction or delivery into interstate commerce of 
adulterated or misbranded foods, drugs, devices, or cosmetics. 
state. 
(b) Their adulteration or misbranding in interstate commerce. 
(c) Their receipt and delivery in adulterated or misbranded 
(d) The introduction or delivery into interstate commerce 
of any article in violation of temporary permit controls (~pplicable 
to food) or in violation of procedures for the introduction of new 
drugs. 
(e) Refusal to permit access to records of interstate ship-
ment of food, drugs, devices, or cosmetics or to make records or 
reports required under procedures for the introduction of~ "new 
drug." · 
. 
(f) Refusal to permit entry and inspection of certain 
establishments in which foods, drugs, devices, and cosmetics are 
manufactured or held. 
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(g) Manufacture of adulterated or misbranded foods, drugs, 
devices, and cosmetics. 
(h) The giving of certain false guarantees regarding good 
faith in receiving or delivering such articles. 
(i) Certain false use of identification devices required 
under law, doing of certain acts which cause a drug to be counterfeit, 
or the sale, dispensing, or holding for sale or dispensing of a 
counterfeit drug. 
(j) Misuse of trade secret information. 
(k) Certain acts resulting in adulteration or misbranding of 
foods, drugs, devices, or cosmetics in interstate commerce. 
(1) Represeriting or suggesting in labeling or advertising 
that approval of a new drug application is in effect or that the drug 
complies with new drug introduction procedures. 
(m) Violation of laws governing the coloring of margarin~. 
(n) The use in sales promotion of any reference to a report 
or analysis furnished under inspection procedures. 
(o) In the case of prescription drugs, failure of the manu-
facturer, packer, or distributor to maintain or transmit to request-
ing practitioners true and correct copies of all printed matter 
required to be included in the drug package. 
(p) Failure of drug manufacturers and processors and de-
pressant or stimulant drug wholesalers, jobbers, or distributors 
to register with the Secretary of Health, Education, and Welfare. 
(q) Relative to stimulant or depressent drugs: manufactur-
ing, processing, or compounding, except by registered drug firms for 
legal distribution; distributing such drugs to persons not licensed 
or authorized to receive them; possession of stimulant or depressant 
drugs except as authorized by law; failure to prepare, obtain, or 
keep required records, and to permit inspection and copying of such 
records; refusal to premit entry or inspeciion as authorized; fill-
ing or refilling prescriptions for these drugs in violation of law. 
Imprisonment for not more than one year or a fine of not more 
than $1000, or both, is the penalty for violation of any of these 
prohibitions. If the violation is committed after a previous con-
viction has become final, or is made with intent to defraud or mis-
lead, the violator is subject to imprisonment for not more than 
three years or a fine of not more than $10,000. or both. 
Drug Abuse Control Amendments. In January, 1963, President 
Kennedy established a President's Advisory Commission on Narcotic 
and Drug Abuse. The Commission made 25 recommendations, the in-
fluence of these being seen in the amendments of 1965. 
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The Drug Abuse Control Amendments of 1965 impose more 
stringent controls on stimulant, depressant, and hallucinogenic 
drugs. The new law, which became effective in 1966, begins with a 
declaration by Congress that these drugs need not move across state 
lines to be subject to its regulations. The law notes that "in 
order to make regulation and protection of interstate commerce in 
such drugs effective, regulation of intrastate commerce is also 
necessary'' because of the difficulties of determining place of 
origin and consumption and because relulation of interstate but not 
intrastate commerce "would discriminate against and adversely affect 
interstate commerce in such drugs." 
The amendments add to the body of law a definition of 
depressant or stimulant drug asr 
(a) one which contains barbituric acid or its salts or a 
derivative therefrom which has been designated under federal law 
as habit forming; 
(b) one which contains amphetamine or its salts or a sub-
stance designated as habit forming by the Secretary of Health, 
Education, and Welfare because of its stimulant effect on the 
central nervous system; and 
(c) one containing a substance designated by regulation as 
having a "potential for abuse" because of its depressant or stimu-
lant effect on the central nervous system or its hallucinogenic 
effect. Narcotic drugs are specifically excluded. 
Lysergic acid and lysergic acid amide are drugs covered by 
the amendments of 1965, along with mescaline and its salts, peyote, 
and psilocybin. The act also prohibits the possession of depressant 
or stimulant drugs except by seven classes of persons--who can be 
generally described as manufacturing or doing research upon the 
drugs. 
No prescription for a depressant or stimulant drug may be 
filled or refilled more than six months after the date of its 
issuance, and no refillable prescription may be refilled more than 
five times. However, prescriptions may be renewed, in writing or 
orally (if reduced to writing and filed by the pharmicist), by the 
prescribing practitioner and then again refilled to the same extent 
as an original prescription. 
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APPENDIX B 
NARCOTIC AND DANGEROUS DRUG LEGISLATION IN OTiiER STATES 
I. State Narcotic Laws 
Narcotics 
Narcotics are divided into five groups by federal law and 
the uniform state narcotic laws: (1) opium and its derivatives --
morphine, heroin, etc.; (2) coca leaves and its derivatives (cocaine): 
(3) cannabis (marihuana); (4) the meperidine (pethidene) group; and 
(5) opiates (substances with an addiction forming or sustaining lia-
bility similar to morphine or cocaine). 
Even though marihuana and cocaine are defined as narcotics 
by law, pharmacologists report that marihuana is a mild hallucinogen 
and cocaine is a strong stimulant, and, except by law, neit~er drug 
is related in any way to the narcotic family. (For further discus-
sion of characteristics of drugs, see President's Crime Commission 
Report, p. 213.) 
Uniform Narcotic Drug Laws 
The uniform narcotic drug act was first promulgated by the 
Commissioners on Uniform State Laws in 1932. Except for California 
and Pennsylvania, all states have adopted the Uniform Narcotic Drug 
Act. However, both California and Pennsylvania have narcotic drug 
laws which are described on pages 8 and 9 of this memorandum. 
In general, the important features of the Uniform Narcotic 
Drug Law are as follows: (1) licensing of pharmacists selling or 
distributing narcotics; (2) licensing of manufactures of narcotics: 
(3) records of narcotics dispensed must be kept by physicians, 
dentists, veterinarians, pharmacists, manufactures, and anyone else 
who can legally dispense narcotic drugs; (4) a listing of narcotic 
drugs that are exempt from law; (5) authorized possession of nar-
cotic drugs; and (6) severe penalties for illegal manufacture, sale, 
distribution, and possession of narcotic drugs. Marihuana has no 
known medical use and possession of this drug is illegal under pro-
visions of the Uniform Narcotic Act. Possession of heroin is also 
illegal, and federal law bans importation of heroin. 
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States Which Have adopted the Uniform Narcotic Drug Law, and An;t 
General Statutory Change The~efrorn 
Uniform Narcotic. Drug Act 




















General S~atutory N_ote s** 
Inserts two sections relating to 
notice, hearing and commitment of 
drug addicts. Code of Ala., Tit. 
22, §§ 249, 250. 
Inserts section providing for con-
finement and treatment in the state 
hospital for the insane of persons 
convicted under this act. A.R.~;. 
§ 36-1022. 
Includes a section providin9 for 
search and seizure on a sworn com-
plaint or affidavit. 
Laws 1955, c. 188, added section pro-
viding for regulations for enforce-
ment and for public hearings upon 
proposals to promulgate new or amen-
ded regulations. C.G.S.A. §§ 19-244 
et seq. 
Inserts sections relating to con-
finement and treatment of addicts 
and manufactur~, possession and sale 
of hypodermic needles. 16 Del. C. 
§§ 4714, 4716. 
Inserts section providing for exam-
ination and treatment of habitual 
users of narcotic drugs, which was 
amended by L. 1935, c. 17120; L. 
1947, c. 23823, § 2; L. 1949, c. 
25035, § 11; L. 1951, c. 26484, § 
10; L. 1953, c. 28233, § 4, and L. 


















General Statutory Notes** 
Inserts section providing for filing 
of an affidavit as to use of narcotic 
d:rugs, and investigation and treat-
ment of users of any narcotic drug. 
L. 1952, p. 324, § 9, substituted 
"Georgia State Board of Pharmacy" for 
"State Commissioner of Agriculture" 
wherever appearing in the Act. Code 
§§ 42-815, 42-818, 42-820. 
Adopts Uniform Act, but makes so 
many changes that it is not feasible 
to set out differences. 
Laws 1929, Act 71, § 3, provided for 
use of word "podiatrist" wherever 
necessary in this Act. R.L.H. 1955 
§§ 52-10 to 52-39. 
Inserts section providing for punish-
ment of violations for which no pen-
alty is specifically provided. I.e. 
§ 17-2822. 
Laws 1957, p. 2569, repealed original 
enactment by L: 1935, p. 723, and en-
acted a new act which is substantially 
similar to the Uniform Act, but con-
tains many variations and additional 
phraseology which are impractical to 
indicate by statutory notes. S.H.A. 
ch. 38, §§ 22-1 to 22-49. 
Substitutes "pharmacist" for "apothe-
cary" throughout and inserts section 
relating to search warrants. 
Laws 1965, c. 195, repealed provisions 
of the Uniform Narcotic Act adopted by 
L. 1937, c. 114 and reenacted new 
provisions substantially similar to 
the Uniform Act but which include 
numerous changes, additions and 
omissions which are impractical to 























General Statutory Notesff 
Contains an additional section re-
lating to the adoption of ordinances 
by cities to control traffic in nar-
cotic drugs, and substitutes "phar-
macist" for "apothecary" throughout 
Act. G.S. 1959 Supp. § 65-2501 et seq. 
Inserted provisions relating to the 
power of the State Board of Health 
or the State Dept. of Health to main-
tain action to restrain or enjoin any 
violation of this Act; search and 
seizure, and possession, sale or use 
of narcotics in penal institutions. 
KRS 218.010 et seq. 
Inserts section providing for searches 
and seizure, affidavits and warrants, 
and penalties for making false affi-
davits. LSA-R.S. 40:972. 
Laws 1965, c. 431, § 16 added pro-
vision relating to forfeiture of con-
traband narcotics and making destruc-
tion of substance in premises to be 
searched, prima facie evidence that 
destroyed substance was unlawfully 
possessed narcotics. 22 M.R.S.A. 
I 2367. 
Inserts section regulating possession 
of hypodermic syringes and needles, 
Code 1957, art. 27, § 297. 
Enacted provisions relating to the 
sale, possession and distribution of 
narcotic drugs which are patterned 
after the Uniform Act provisions, but 
because of the many variations there-
from which cannot be set out in stat-
utory notes, reference should be made 
to the State code. M.G.L.A. c. 94, 
§ 197 et seq. 
Inserts section relating to enfor-













New Hampshire 1963 
New Jersey 1933 
New Mexico 1935 
New York 1933 
North Carolina 1935 
General Statutory Notes..., 
Laws 1953, p. 625, added section 
. relating to search warrants, and 
seizure of narcotics. 
Laws 1957, p. 679, inserted provi-
sions relating to forfeiture of 
vehicle or craft transporting nar-
cotic drugs, and regulations by the 
director of division of health. 
Sections 195.025, 195.135, 195.145, 





five sections relating to 
seizure and forfeiture of 
R.C.M. 1947, §§ 54-112 to 
Adopted Uniform Act by L. 1933, c. 
51; Comp. Laws§§ 5090 to 5090.25. 
This enactment, however, was held 
unconstitutional because of defec-
tive title, and the Uniform· Act was 
again enacted, without reference to 
the prior statute, by L. 1937, c. 
23. N.R.S. 453.010-453.240. 
Contains numerous additional pro-
visions. 1953 Comp. §§ 54-7-1 to 
54-7-49. 
Adds sections setting up the bureau 
of narcotic control, and relating to 
use of opium pipes and to obtaining 
drugs from one physician while under 
treatment from another. McKinney's 
Public Health Law, §§ 3302, 3303, 
3304, 3312, 3340, 3343, 3350, 3351. 
Inserted provisions relating to the 
possession of hypodermic syringes 
and needles, growing narcotic plants 
by unlicensed persons, seizure and 
forfeiture of vehicles, vessels or 
aircraft used in transporting nar-
cotics, and reports by physicians. 









Rhode Island 1934 
South Carolina 1934 
South Dakota 1935 
Tennessee 1937 
General Statutory Notes-IHI-
Laws 1955, p. 178, amended entire act 
which contains many variations and 
additional phraseology which are im-
practical to indicate by statutory 
notes. 
Laws 1959, p. 1044, amended provi-
sions relating to record of drugs, 
drug contents, exemptions and pen-
alties, but because of the many 
variations from the Uniform Act, . 
reference should be made to the State 
Code. R.C. § 3719.01 et seq. 
Contains additional provisions re-
lating to classification of new prod• 
ucts as narcotic drugs and dispensa-
tion of narcotics on oral prescrip-
tion pursuant to the rules and regu-
lations of the Secretary of Treasury 
of the United States. 63 Okl. St. 
Ann. §§ 401.1• 425. 
Adds following section: "The Board 
of Pharmacy shall make all needed 
rules and regulations for carrying 
the provisions of this act fnto 
effect." 
Laws 1961, c. 572, added provisions 
relating to exempt status of narcotics. 
ORS 474.010-474.990. 
Contains several additional sec-
tions. Gen. Laws 1956, §§ 21-28-1 
to 21-28-67. 
Act contains an additional pro-
vision relating to proceedings 




















General Statutory Notes** 
Laws 1953, c. 328, p. 812, § -5, 
added a section requiring finger-
printing and photographing of per-
sons arrested and persons convicted, 
and requiring the courts to notify 
the Department of Public Safety of 
the disposition of any case. 
Vernon's Ann. P.C. art. 725b, § 18a. 
Repealed original enactment by L. 
1935, c. 80, and enacted a new act 
which is substantially similar to 
the Uniform Act as amended in 1952; 
includes a section providing for 
seizure and disposition of narcotics 
and dope pipes or apparatus. U.C.A. 
1953, 58-13a-1 et seq. 
Laws 1951, No. 170, §§ 135-158, re-
pealed original enactment by·L. 1945, 
No. 113 and reenacted substantially 
similar provisions. 18 V.S.A. §§ 
4141-4163. 
Inserts section relating to search 
and seizure. 
Laws 1959, c. 27 repealed the former 
adoption by L. 1951, c. 22 and re-
enacted substantially similar pro-
visions. RCW 69.33.220-69.33.970. 
Inserts three sections relating to 
search warrants, chloral hydrate and 
malonylurea. Code, §§ 16-8A-19 to 
16-8A-21. 
Adds sections relating to adver-
tising narcotics, possession of 
opium pipes, possession and use of 
marijuana and drug addicts. W.S.A. 







General Statutory Notes** 
Inserts section relating to issu-
ance of warrant. W.S. 1957, § 35-
362. 
* Quoted from Uniform Laws Annotated, Volume 98, 1966, pp. 409-410, 
412-414. 
** Because of the numerous amendments to the various state enact-
ments of the Uniform Narcotic Drug Act, it is not feasible to 
attempt to show all of the resulting variations by statutory 
notes, and it is suggested that reference be made to the particular 
state code for the text of the corresponding provisions. 
States Which Have Not Adopted the Uniform Narcotic Drug Law 
California has a comprehensive narcotic law which is found in 
West's Anno. California Codes -- Health and Safety, Section ·11000 et 
seq. 
All drugs found in the uniform narcotic drug law are listed 
under California's narcotic drug law, although California lists each 
drug separately (Sec. 11001). California also has provisions for 
an exempt list (Sec. 11200) and provisions for keeping records (Ch. 
3, Arts. 3-6) which are also similar to the uniform law. Unlike 
the uniform law, California has made provisions for a Division of 
Narcotic Enforcement found in the State Department of Justice (Sec. 
11100). The chief and all inspectors of the division have all of 
the powers and duties of police officers of the state (Sec. 11105). 
Physicians dispensing narcotic drugs are licensed by the 
state and, upon the request of the physician or upon request of 
the state, a physician can have his narcotic license revoked (Sec. 
11163). Narcotic addi-cts cannot receive narcotics from a physician 
unless the addict has received permission from the division (Sec. 
11164). California's narcotic law provides for treatment of nar-
cotic addicts (Ch. 4, Arts. land 2). 
The penalties for illegal manufacture, sale, distribution, 
transportation, and possession of narcotic drugs, including marihuana 
and cocaine, are generally more severe than the uniform narcotic drug 
law (Ch. 5). For example, illegal transportation and illegal sale or 
distribution carries a felonr penalty of from five years to life for 
the first offense (Section 1 531). The final chapter of the Calif-
ornia narcotic law, Chapter 7, provides for enforcement of the law. 
The Pennsylvania drug law includes the same features as 
contained in the uniform narcotic drug law. (Purdon's.Penna. 
stat. Anno., Vol. 35, Health and Safety -- Ch. 6, Section ?80 et 
seq.) However, the Pennsylvania act is unique because it includes 
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provisions for both narcotics and dangerous drugs which other states 
usually provide in separate statutes. 
II. Current State Laws Controlling Dangerous Drugs 
Dangerous Drugs 
The dangerous drug classification, as described by the 
federal food and drug administration, contains four large cate-
gories of non-narcotic drugs for control purposes. (Under federal 
law both marihuana and cocaine are narcotics.) The four groupings 
are: (1) depressants; (2) stimulants; (3) hallucinogens; and (4) 
combinations drugs -- stimulants and depressants combined. 
The depressants are probably the most dangerous of this 
group because tolerance develops -- larger quantities of the drug 
are required to receive the same effects -- and both physical and 
psychological dependence develops. During withdrawal, the abstin-
ence syndrome is present and, unless proper medical care is given 
to the addict, he may die during withdrawal. Medical author'ities 
believe that addiction to depressants presents a greater danger 
than addiction to narcotics. Under current federal law, the de-
pressants which are controlled (by generic classification and not 
by trade names) include: (1) Chloral hydrate (chloral); (2) 
ethchlorvynol (placidyl); (3) ethinamate (valmid); (4) glutethimide 
(doriden); (5) methyprylon (noludar); (6) paraldehyde; l7) lysergic 
acid; (8) lysergic acid amide; (9) chloral betaine (beta-chlor); 
(10) chlorhexadol (lora); (11) petrichloral (periclor); (12) 
sulfondiethylmethane (tetronal); (13) sulfonethylmethane (trional); 
(14) sulfonmethane (sulfonal). 
Stimulants are drugs which stimulate the central nervous 
system. Like depressants, tolerance can develop for stimulants. 
However, physicians agree that physical dependence does not develop 
so there are no withdrawal symptoms from stimulants. Stimulants do 
create a psychological dependence. Stimulants controlled by federal 
law (by generic classification) include: (1) d-f dl-methamphetamine 
(d-, dl-desoxyephedrine) and their salts, and (2J phenmetrazine 
(preludin) and its salts. 
Probably the greatest controversy in recent years has been 
over the use of hallucinogens. There is, at present, no known 
medical use for these drugs, and they are legally available only to 
qualified clinical investigators. Experimentation with hallucinogens 
has brought many controversies into the foreground. As was discussed 
in committee hearings, some researchers claim that LSD can cause 
damage to the chromosomes. Other investigators believe that pro-
longed use will cause permanent damage to the normal brain patterns. 
What is known about these drugs are: (1) tolerance does not 
develop; (2) there is no physical dependence, which means there 
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are no wi thclrawal syrnpt-ern's; · ( 3) 'f>'sychological dependence probably 
can develop,_ stic-h as irn 'U'se of alcohol and tobacco; and (4) peo- · 
ple who use hallucinogens. continu'ously probably have some inner 
problems whlch are removed when t 11¥e hallucinogenic drug is 
administered. 
Curre-nt f-ederal l~w 'cOnt~ts the following hallucinogerlic 
drugs (by 9enericcla~sifieati~n): (1) DMT ~dimethyl-tryptami'ne,); 
(2) LSD; LSD-25 {d-lysergi,c acid diethylamide); (3) mescaline and 
its salts; (·4) peyOt'e (~visio'n_s <>f the federal law do 11ot _apply 
to ncrh-drug us-e in bona fhi-e religi-ous ceremonies of t-pe N·ative 
American Church.); (5) .Y,silocybin~ psilocibi,n; (6) psil6cyn, 
psilocin. 
Model_ State JJrug Abu.se. Co.ntr.o:l. Ac..t 
The model state drug abuse act was promulgated by the U.S. 
Department of Heal th, Educati'on, and. Welfare. This act has the 
endorsement of the pharmaceutical m·a"t,uf actures because a unif·orm 
act will make 1 t easier to ·tneiet state r·egµlations. The Federal 
Bureau of Drug Abuse Gonttol elso w~uld like to have the act' 
passed because it is very similar b:, federal law. A drug abuse 
act would also aid the bureau bee-ause the bureau could then work 
with local police agenties. 
Important features of the a:Ct include: ( 1) requires a 
system of record keeping for al~ ~~~ple dealing with dangetous 
drugs; { 2) pt-ov!des for inspectliefts of records; ( 3) gives in·spector 
all powers and duties of other le\19 enforcem~nt agencies; {4} gives 
the inspector powers of seateh end s1!lzure: (5) provides penalties 
for illegal ~anufattu~e, sal~ or dtst~ibution, and possession 
(penalties are left to tht_di~tt~tlon of the state); and(~) 
seizure of illegal drugs ~ithout, a search warrant and possible 
confiscation of vehicles lnvolve'cf in transportation of illegal 
dangerous drugs. 
Dangerous .D;cugs. Con.trolled. Bi States 
State 0 a 't•·* .epr.e s.s .. o. s Hallu,cimigens* Stimulants* ~ 
Alabama M 
Alaska X 
Arizona X Possibly** X 
Arkansas )t X X 
California X ,t X 
Colorado Peyote only 
Connecticut X X X 
Delaware X 
Florida X X X 

















































































































































* These classifications are broad, and some states do not control 
all drugs under the general classification. ,-
** Any state which has given the authority to an agency to name 
dangerous drugs could have already included these drugs under 
rules and regulations which would not be found in the statutes. 
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States Which J:lave Adpp.t~d th, Mgc;l~l Drug .Ab,u,sg Cp.n.trol Act 
Arkansas -- Arkansas Statutes Anno •• Vol 7A, Title 82 
Chapter 1. 
Arkansas recently passed the model drug abuse control act, 
However, the law library does not have Arkansas' 1967 Session Laws 
at this time, and the staff is unable to provide the ~xact citation. 
From information received from the Federal Bureau of Drug Abuse 
Control, Arkansas has provisions for 9trong possession penalties, 
seizure of controlled dangerous drugs without a s@l~ch wattant, and 
state inspectors have all police powe~s. 
Georgia -- Code of Georgia Anno., Book 14A, Title 42 Chapte~ 
42-7 and 42-99. Georgia Laws of 1966, Vol. 1, Chapte~ 501 ts.a. 80) 
p. 371. 
With the 1966 am~ndm~nt to Georgia's Dangerous Drug Act (Ch. 
42-7), Georgia has all of the provisions found in the modfl drug 
abuse control act-· Chapter l; Section l; Ga. L. 1966, page 372. 
The penalty for violation of the dangerous drug law ig a misdemean~r. 
Hawaii•- Hawaii adopted the model drug_abuse control act in 
1967. Hawaii's 1967 Session Lawe are not available, and a citation 
cannot be given. Acco~ding to information ~eceivtd from the Federal 
Bureau of Drug Abuse Control, Hawaii's law includes: (1) possession 
penalties; (2) seizure of illegal dangerous drugs without a search 
warrant; and (3) seizure of vehicles used in transporting illegal 
dangerous drugs. All other f~atu~es of th~ model act are the s•me, 
Idaho -- Idaho Code, Vol, 7, Health and Safety, Title j7, 
Chapter 3~. 
Idaho has adopt~d the mod~l drug abuse control act~ The 
agency administering the law is the Idaho Stata Bc,ard of Pharmacr 
(Sec. 37-3320). The penalty for illegal manufacture, i11egal 9a e 
or distribution, illegal possession, and selling counterfeit drugs 
is a felony. Violations of other prohibited acts is a misdemeanor 
(Sec. 37-3304). 
Minnesota -- Minnesota had laws regulating depressQnt drugs 
and peyote. but in the 1967 legislative session, Minnesota passed 
the model drug abuse control act, This information was re~eived 
from the Federal Bureau of Drug Abuse C~ntrol, and since Minn~sota 
has not sent their 1967 Session Laws to the law library, the staff 
is unable to provide a statute citation. 
Nebraska -- According to the Federal Bureau of Drug Abuse 
Control, Nebraska adopted the model drug abuse control act, Un-
lawful possession of dangerous drugs is subject to seizure without 
a search warrant, and vehicles used in t~ansportation of illicit 
dangerous drugs are subject to confiscation. 
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New Jersey -- New Jersey Session Law Service, 1967, No. 1, 
Chapter 314, p. 25 et seq. 
New Jersey has adopted the model drug abuse control act. 
There are no special provisions for confiscation of illicit danger-
ous drugs or vehicles used in transportation of illegal dangerous 
drugs. Penalty for violating the act is a misdemeanor, punishable 
by fine only (Sec. 9, p. 31). 
New Mexico -- New Mexico Statutes 1953, Vol. 8, Part 2, 
Sections 54-6-25 to 54-6-51. 
Controlled drugs are stimulants, depressants, and halluci-
nogens (Sec. 54-6-27F). Illicit dangerous drugs are subject to 
seizure without a search warrant. Vehicles transporting these 
drugs are also subject to confiscation (Sec. 54-6-31). Penalties 
for violation of the New Mexico Drugs and Cosmetics Law are: (1) 
violation of Sec. 54-6-28A, B, C, and G is a misdemeanor on first 
offense and a felony on the second and subsequent offenses (illegal 
manufacture, illegal sale or distribution, and illegal possession 
of dangerous drugs) -- Sec. 54-6-51A. 
New York -- New York has passed the model drug abuse act 
controlli .. g dangerous drugs, but no further information is avail-
able. 
South Carolina -- Code of Laws of South Carolina, Vol. 7, 
Title 32, Section 32-1505 et seq. 
During the 1966 legislative session South Carolina passed 
the model drug abuse control act, controlling stimulants, depres-
sants, and hallucinogens (Sec. 32-1505). Seizure of illegal 
dangerous drugs may be made only if a search warrant has been 
properly executed lSec. 32-1510.2). No provisions are made for 
confiscating vehicles used in transportation of illegal dangerous 
drugs. Penalties for violation of the law include: (1) first 
offense a misdemeanor -- maximum $2,000 fine or two years imprison-
ment or both; (2) second offense -- fine of not less than $2,000 
nor more than $5,000 or imprisonment of not less than two nor more 
than 5 years -- discretion of the court; and (3) third and subse-
quent offenses -- imprisonment of not less than five nor more than 
ten years with no probation or suspension. Sec. 32-1510.3. 
Tennessee -- From information received from the Federal 
Bureau of Drug Abuse Control, Tennessee passed the model drug abuse 
control act during the 1967 legislative session, but no further 
information is available. 
Utah 
to 58-33-8. 
Utah Code Anno., Vol. 6, Title 53, Sections 58-33-1 
During the 1967 legislative session, Utah passed the model 
drug abuse control act, which controls stimulants, depressants, and 
hallucinogens (Sec. 58-33-1). Utah law gives authority to the 
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department of business regulation to seize illegal dangerous drugs 
and vehicles used in transportation of illegal dangerous drugs 
without a search warrant (Sec. 58-33-5). Penalties include: (1) 
sale to a minor -- felony; and (2) any other violation is a mis-
demeanor (Sec. 58-33-4). 
Virginia -- Code of Virginia, Vol, 1. Title 54, Sections 
54-446.3 to 54-446.13. 
Virginia has adopted the model drug abuse control act. 
Controlled drugs are stimulants, depressants, and hallucinogens 
(Sec. 54-446.3}. It is unlawful to illegally possess, sell or 
distribute, or manufacture these dangerous drugs (Sec. 54-446.4). 
Records are to be kept for three years (Sec. 54-446.5). The law 
makes no mention of seizure of dangerous drugs or seizure of 
vehicles transporting illegal dangerous drugs. Penalties for 
violation of the act include a misdemeanor for the first offense 
and a felony for any subsequent offense (Sec. 54-446.11). 
Wyoming -- Session Laws of Wyo~ing, 1967, Chapter 158, 
pp. 462-471. 
Wyoming has enacted the model drug abuse control act which 
controls stimulants, depressants, and hallucinogens (Sec. 1, p. 
463). Illegal dangerous drugs can be seized with a search warrant 
and vehicles used in transporting-illegal dangerous drugs can be 
confiscated (Sec. 5, p. 465). Penalty for violation of the law is 
a misdemeanor (Sec. 4, p. 465). . · 
States Controlling Stimulants, Depressants. and Hallucinogens or 
Have Given an Agency Authority to Add Dangerous Drugs to a Dangerous 
Drug List, but Have Not Adopted the Model Drug Abuse Control Act 
Arizona -- Arizona Revised St~tutes Anno., Vol. 10, Section 
32-1964 to 32-1975. · 
Ariz~na cbntrols stimulants an~ depressants~ and iri addition 
the state board of pharmacy has the authority to add dangerous drugs 
to the list (Sec. 32-1964). Records of sale of dangerous drugs 
shall be kept for five years (Sec. 32-1965). Arizona law makes it 
unlawful to illegally sell or possess-dangerous drugs (Sec. 32-1968). 
The penalty provided by the law is a m~sde~eanor (Sec. 32-1975). 
California -- West's Anno. California·codes; Business and 
Professions Section 4210 et seq. and Health and Safety Section 
11901 et seq. 
Stimulants and depressants are controlled drugs in California 
Business and Professions Code Section 4211. Everyone dealing with 
· stimulant.and depressant drugs are required to obtain a license from 
the state (Sec. 4222). Whenever stimulant or depres~ant drugs are 
administered or dispensed records of the sale have to be kept (Sec. 
4227 and Sec. 4232). Possession of stimulant or depressant drugs 
without a prescription is illegal (Sec. 4230). Any violations of 
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the dangerous drug law will carry the penalty of a misdemeanor 
(Sec. 4233), and in tp~ case of a doctor or pharmacist, conviction 
may result in suspeniJ6n or revocation of any license issued under 
the provision of the .Business and Professions Code (Sec. 4238). The 
state board of pharmacy $hall have inspectors with powers and duties 
of legally empowered: p,e,ace officers (Sec. 4221) • Inspectors shall 
have the power to inspect inventory stocks of dangerous drugs and 
records pertaining to sale of dangerous drugs (Sections 4231 and 
4232). . · 
In 1966, California passed a new law restricting dangerous 
drugs. This law included stimulants, depressants, and hallucino-
genic drugs (LSD and DMT) -- Health and Safety Code, Section 11901. 
Unlawful possession of restricted drugs shall on the first offense 
be a misdemeanor and ,u~Qn each offense thereafter a felony (Sec. 
11910). Unlawful sale o,.r <::listribution, manufacture, transporta-
tion, etc., shall be a felony (Sec. 11912). Anyone attempting to 
involve a minor in restricted dangerous drugs shall be, upon con-
viction, sentenced tb the ~tate penitentiary (Sec. 11913). The 
provisions of the law d9 not apply to legal clinical investigators 
of LSD and DMT (Sec. 11916). 
Connecticut .. -·The 1967 session of the Connecticut Legisla-
ture passed a dangerqU$ drug abuse law; however, the 1967 Connecticut 
Session Laws have not been received by the law library and the staff 
will not be able to give the citation of the law. According to in-
formation received from the Federal Bureau of Drug Abuse Control, 
Connecticut's drug a,i;>use law was patterned after the model drug 
abuse control act, but the Connecticut law is more comprehensive. 
Florida~- Florida Statutes Anno., Title 27, Sections 404.0l 
to 404.15. 
Controlled drtlgs in Florida are stimulants and depressants 
(Sec. 404.01). Prohibited acts include: unlawful possession and 
failure to keep records {Sec. 404.02). Anyone dealing with stimu-
lants or depressants' is required to keep records for a period of 
two years (Sec. 404.05). Records shall be open to inspectors from 
the Florida State Bo~rd of Health (Sec. 404.06). Any stimulants or 
depressants not meeting the requirements of the chapter shall be 
labeled contraband and shall be subject to seizure and confiscation 
by any law enforcem&nt officer (Sec. 404.07). Any vehicle, vessel, 
or aircraft carrying lontraband shall also be subject to seizure 
and forfeiture (Sec, 404.08). The Florida Board of Health has the 
authority to make rules and regulations deemed necessary to imple-
ment the law (Sec. 404.12). Penalty for violation of the law is 
a felony (Sec. 404.15), Anyone licensed to administer drugs may 
have his license revoked upon conviction of any violation of the 
law (Sec. 404.14). The Florida Legislature amended Chapter 404 by 
adding a new section, Section 404.001. The name of the law was 
changed to the Florid~ Drug Abuse Law (Chapter 67-136, 1967 Regular 
Session). The only impQrtant change in the law was the addition of 
hallucinogenic drtigs to"th~ list of controlled drugs (Sec. 404.01(3)). 
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Indiana -- Burns Indiana Statutes Anno., Vol. 7, Part 1, 
Health ~ode, Title 35, Sections 35-3331 to 35-3339. 
The Indiana Dangerous Drug Act controls stimulants, depres• 
sants, and hallucinogenic drugs (Sec. 35-3332J). Unlawful acts 
include: (1) illegal sale; (2) illegal possession; (3) failure to 
keep records of sales; (4) refusal to permit inspection of records; 
and (5) attempting to obtain drugs by fraud (Sec. 35-3333). Upon 
conviction of these unlawful acts the penalty is a felony (Sec. 35• 
3338). 
Louisiana -- Louisiana Revised Statutes 1950, Title 40, Public 
Health and Safety, Part X, Narcotics Sub•Part D, Sections 1031 to 1046. 
Louisiana law controls stimulants, depressants, and hallucino~ 
genie drugs (Sec. 1032). Unlawful acts include: (1) illegal sale; 
{2) illegal possession; (3) failure to keep records; (4) refusal to 
open records to inspectors; and (5) attempting to obtain dangerous 
drugs by fraud (Sec. 1033). Louisiana law has provisions for clini-
cal researching of dangerous drugs (Sec. 1035). Records are to be 
kept as mar be reasonably required by the state board of pharmacy 
(Sec. 1036. The state board of pharmacy shall have the authority 
to inspect records (Sec. 1037). All illegallr possessed dangerous 
drugs are considered contraband subject to se zure and confiscation 
by any law enforcement officer (Sec. 1038). Penalty for violation 
of the Louisiana dangerous drug law is a fine of not more than $1,000 
or imprisonment in the parish jail for two years or both. For each 
subsequent offense punishment shall be not more than a $5,000 fine or 
confinement in the state penitentiary for a period of not more than 
five years, or both imprisonment and fine (Sec. 1046). · 
Maine•- Maine Revised Statutes Anno., Vol 12, Title 22, 
Health and Welfare, Section 2201 et seq., as amended by the Maine 
Session Laws 1967. 
The board of commissioners of the profession of pharmacy 
shall regulate all stimulants and depressants (Sec. 2201). It is 
urilawful to possess or sell depressant drugs unless a pre~cription_ 
fQr the drugs has been obtained from a doctor (Sec. 2210). In the 
amended law a new section (2212B) makes it a felony to possess 
hallucinogenic drugs. Anyone found with illegal possession of 
drugs enumerated in Sections 2201 to 2210 {Narcotic drugs mentioned 
in these sections are not discussed) shall be guilty of a felony. 
If a person is found under the influence of these enumerated drugs, 
the individual is guilty of a felony. Inspectors shall have the 
right to inspect all records (Sec. 2215). 
Section 2368 {a section in Maine's narcotic law) concerning 
licensing of manufacturers and wholesalers was amended in 1967 to 
prohibit any manufacturing of hallucinogenic drugs. Clinical re-
searchers shall be licensed and controlled by the bureau of health. 
Penalty for illegally manufacturing hallucinogenic drugs is ad-
ministered under the narcotics penalties. 
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Maryland -- Anno. Code of Maryland, Art. 27, Sec. 307 et 
seq. and Art. 43, Sections 285 and 289 as amended in 1966. 
Maryland defines dangerous drugs as any drug intended for 
man which may have potentially harmful effects unless administered 
under the supervision of a physician (Sec. 307). The state depart-
ment of public hP-alth is authorized to promulgate the necessary 
rules and regulations for the administration of the act (Sec. 312). 
Violation of the act is a felony (Sec. 313). Unlawful acts are: 
(1) illegal possession of stimulants and depressants; (2) failure 
to keep records; and (3) illegal manufacture of a stimulant drug 
Laws of Maryland 1966, Chapter 377, pp. 666-669. 
Massachusetts -- Massachusetts General Laws Anno., Ch. 94, 
Art. 187A et seq. as amended in 1967. 
Under Massachusetts law harmful (dangerous) drugs include 
stimulants, depressants, and hallucinogens {Sec. 187A and 1967 
Regular Session Ch. 49). Illegal sale is a misdemeanor (Sec. 94-
187A). Illegal possession of dangerous drugs is a misdemeanor 
(Sec. 94-187B). 
_Michigan -- Michigan Statutes Anno., Vol. 13, Regulations 
Under Police Powers, Title 18, Sections 18.1101 to 18.1108 as 
amended. 
Michigan law controls the sale and possession of stimulants 
and depressants. Records of sale must be kept by all licensed 
dispensers of these drugs (Sec. 18.1101). All records must be kept 
for a period of two years (Sec. 18.1104). Anyone guilty of, any 
violation of Section 18.1101 to 18.1105 is guilty of a misdemeanor. 
Anyone distributing, selling, or in possession of any hallucino-
genic drugs except exemption provided for by the Federal Food Drug 
and Cosmetics Act is guilty of a felony (Sec. 18.1106 -- amended 
during the 1966 legislative session, Mich. Stat. Anno., Statute 
Release No. 7, p. 305). Administration of the act is carried out 
by the state board of pharmacy (Sec. 18.1108). 
Missouri -- Missouri Revised Statutes, Cumulative Supplement 
1965, Chapter 195.240 et seq. 
Illegal possession, illegal sale or distribution, and illegal 
manufacturing of stimulant and depressant drugs is a felony in 
Missouri (Sec. 195.240 and 195.270). From information received 
from the Federal Bureau of Drug Abuse Control, Missouri has included 
hallucinogenic drugs under this statute, but the 1967 Missouri 
Session Laws are not available and the staff cannot give a citation. 
Montana -- Revised Codes of Montana 1947, Replacement 2, 
Part 2, Title 27, Section 27-701 et seq. 
Stimulant and depressant drugs are controlled in Montana 
(Sec. 27-716). Any violation of Section 27-716 shall be deemed a 
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misbranding of a drug or device, The penalty for misbranded drugs 
or devices is a misdemeanor (Sec. 27-705). It is unlawful to manu-
facture, sell or distribute, and possess any hallucinogenic drugs 
as defined by federal law unless authorized by the Montana Depart-
ment of Public Health or under provisions of the federal act (Sec. 
27-724). Penalty for violation of Section 27-724 is a misdemeanor 
on first offense and a felony on the second or subsequent offenses 
(Sec. 27-725). 
Nevada -- Statutes of Nevada, 1965 Special Session, 1966 
Special Session, and 1967 Regular Session, Vol. 2, pp. 1629 et seq. 
Nevada controls stimulants and depressants (Sec. 13, p. 1631). 
Records of dangerous drugs are to be kept and open to inspection by 
authorized inspectors (Sec. 18, p. 1633). Unlawful sale of danger-
ous drugs to a minor is a felony (Sec. 20, p. 1633). Unlawful pos-
session of dangerous drugs is a misdemeanor (Sec. 21, pp. 1633 and 
1634}. Hallucinogenic drugs are controlled by Sec. 48, p. 1636 of 
the law. It is a misdemeanor to illegally possess, sell or dis-
tribute and manufacture any drug which may not be lawfully intro-
duced into interstate commerce under the Federal Food, Drug, and 
Cosmetic Act (Sec. 62, p. 1639). 
Nrrth Carolina -- General Statutes of North Carolina, Vol. 
2C, Section 90-lll.3 et seq. as amended in 1967. 
Stimulants and depressants are controlled drugs in North 
Carolina (Sec. 90-113.1). Prohibited acts under the law include: 
(1) illegal sale or distribution; and (2) illegal possession of 
stimulants and depressants (Sec. 90-113.2). The board of pharmacy 
is the controlling agency (Sec. 90-113.6). Records are to be kept 
for a period of two years (Sec. 90-113.5). Penalty for violation of 
the law is first offense a misdemeanor and each offense thereafter 
a felony (Sec. 90-113.7). In 1967 a new subsection (b) was added 
to Sec. 90-113.7 which gave the state authority to seize and dispose 
of any vehicle, vessel, or aircraft under 7,000 pounds which is 
used for transportation of stimulants or depressants. 
The North Carolina narcotic drug act was also amended in 
1967. Added to the narcotics definition were all hallucinogenic 
drugs (Sec. 90-87). The hallucinogens are now subject to all pro-
visions of the uniform narcotic drug law. 
Oregon -- Oregon Revised Statutes, Vol. 3, Title 37, Chapter 
475.010 et seq. 
The drug advisory council has the authority to designate 
dangerous drugs (Sec. 475.010). The staff was not able to deter-
mine which drugs are controlled in Oregon. Sale or possession of 
dangerous drugs without a prescription is illegal (Sec. 475.100). 
Violation of Section 475.100 is a misdemeanor (Sec. 475.990 (2)). 
Pennsylvania -- Purdon's Penna. Statutes Anno., Title 35, 
Section 35-780-1 et seq. 
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Dangerous drugs which are controlled are : ,(1) stimulants; 
(2) depressants; and (3) any other drug, because of its toxicity 
or potentiality for harmful effect is considered unsafe for use 
except under a physician administration (Sec. 780-2 (h)). The 
secretary of health after consultation with the Pennsylvania Drug, 
Device, and Cosmetic Board has the authority to add drugs to the 
dangerous drug list (Sec. 780-2 {h)). All possession of dangerous 
drugs, except as provided by law, is contraband (Sec. 780-2 lv)). 
Records of dangerous drug sales and purchases are to be kept for 
two years, and the records are open to inspection by authorized 
persons (Sec. 780-9). Any persons dealing in dangerous drugs must 
- register with the secretary of health (Sec. 780-11). All contra-
band drugs are subject to seizure (Sec. 780-12). Unlawful acts 
include: (1) illegal manufacturej (2) illegal sale or distribu-
tion; and (3) illegal possession \Sec. 780-4 (a)). Penalties for 
violation of the dangerous drug portion of the law is a misdemeanor 
for the first offense and a felony for each subsequent offense 
(Sec. 780-20 {a)). 
Texas -- Vernon's Penal Code of the State of Texas, Vol. 2, 
Article 726d et seq. as amended. 
Dangerous drugs which are controlled in Texas include stimu-
lants, depressants and hallucinogens (Art. 726d, Sec. 1~ as amended 
in 1966 and 1967). Prohibited acts include illegal manufacture, 
illegal sale or distribution, and illegal possession (Art. 726d, 
Sec. 3). Records are to be kept and open to inspection (Art. 726d, 
Sec. 6). Dangerous drugs unlawfully possessed are subject to 
seizure (Art. 726d, Sec. 8). Penalties include: (1) first offense 
a maximum fine of $3,000 or imprisonment for not less than-30 days 
nor more than two years or both; and (2) second or subsequent offense 
a felony. 
Washington -- Revised Code of Washington, Vol. 9, Title 69, 
Chapter 69.40 et seq as amended in 1965). 
Dangerous drugs are any drugs which require a prescription 
(Sec. 69.40.063). Upon receiving a search warrant dangerous drugs 
can be seized (Sec. 69.40.100). Any place distributing dangerous 
drugs illegally shall be deemed a public nuisance (Sec. 69.40.080). 
Unlawful acts include: (1) illegal sale or distribution; (2) 
illegal possession; and (3) illegal manufacture of dangerous drugs 
(Sec. 69.40.061, 69.40.063, 69.40.080, 69.40.090, and 69.40.100). 
Stimulants and depressants are specifically named as dangerous 
(Sec. 69.40.060). Penalties for violation of this law include: 
(1) first offense -- a misdemeanor; (2) second offense -- gross 
misdemeanor -- Maximum of $1,000 fine or one year imprisonment or 
both; (3) third or subsequent offense -- a felony; and {4) sale or 
distribution to a minor -- a felony (Sec. 69.40.070). According to 
information received from the Federal Bureau of Drug Abuse Control, 
hallucinogenic drugs were added as controlled drugs during the 1967 
regular session. No information is available from the law library 
and an exact citation is not possible. 
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West Virginia -- Acts of the Legislature of West Virginia 
1965, Chapter 133, pp. 503-508. 
West Virginia controls stimulants and depressants specifically 
and hallucinogens by reference to the federal law and any amendments 
to the federal law (Sec. 1(1), p. 504). Prohibited acts include: 
(1) unlawful sale or distribution; and (2) illegal possession of 
dangerous drugs (Sec. 2, pp. 506 and 507). Regulations to imple-
ment this law are made by the state board of pharmacy (Sec. 4, p. 
508). Illegal dangerous drugs can be seized with a search warrant 
(Sec. 5, p. 508). Penalty for violation of the act is: (1) first 
offense -- fine not to exceed $1,000 or imprisonment for not more 
than five yearsi and (2) second or subsequent offense -- a felony 
(Sec. 6, p. 5081. 
States Controlling Some Dangerous Drugs 
Alabama -- Act No. 430, Acts of Alabama, Special Session 
1966, p. 575. 
Alabama law makes it unlawful to possess, transport, deliver, 
sell, offer for sale, bater, or give away in any form LSD, psilocybin, 
or any other drug or compound known as psycotomimetics (hallucino-
gens) (Sec. 1). Section 4 of the act provides for a felony penalty 
for illegal possession, transportation, and sale or distribution. 
Alaska -- Alaska Statutes, Title 17, Chapter 15. 
Section 17.15.010 states that it shall be unlawful t~ sell, 
barter, distribute, or give away depressant drugs. The penalty for 
illegal sale is a misdemeanor (Sec. 17.15.040). 
Colorado -- Sections 48-4-1 to 48-4-4, C.R.S. 1963. 
Colorado controls sale or distribution of anhalonium and 
peyote (Sec. 48-4-2). The penalty for illegal sale is a mis-
demeanor (Sec. 48-4-3). 
Delaware -- Delaware Code Anno., Title 16, Sections 4901 to 
4905. 
Delaware controls depressant drugs (Sec. 4901). The law re-
quires the keeping of records, and the proper labeling of containers 
(Secs. 4903 and 4904). There are no provisions for penalties. 
Kentucky 
Health. 
Kentucky Revised Statutes, Title 18, Public 
Depressant drugs are controlled by Kentucky law (Sec. 217.461). 
Unlawful acts include: ( 1) ille·gal sale; ( 2) illegal manufacture; 
and (3) illegal possession (Sec. 217~462 (1)). Records of sale must 
be maintained for at least two years and the records shall be open 
to inspection to authorized representat~ves of the state board of 
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health and the state board of pharmacy (Sec. 217.511). Kentucky 
law controls stimulants under section 217.720. It is unlawful to 
illegally possess, sell, and manufacture stimulants (Sec. 217.730). 
The state board of health and the state board of pharmacy shall 
regulate this law. Inspectors shall have all police powers (Sec. 
217.790). There is no specific regulation requiring keeping of 
records for stimulant drugs. Penalty for violation of the depres-
sant law is a misdemeanor (Sec. 217.992). Penalty for violation 
of the stimulant law is a misdemeanor. 
Mississippi -- Mississippi Code 1942, Anno., Vol. 5A, Public 
Welfare, Sections 6831-01 to 6831-12. 
Controlled drugs in Mississippi are stimulants and depres-
ants (Sec. 6831-01). Prohibited acts include: (1) illegal distri-
bution or sale; (2) illegal possession; and (3) failure to keep re-
cords or refusal to allow inspectors to inspect records (Sec. 6831-
02). Manufacturers and pharmacists are required to keep records of 
stimulants and depressants for two years (Sec. 6831-05). Records 
shall be open to inspectors from the state board of pharmacy upon 
written request (Sec. 6831-05). The state board of pharmacy is 
authorized to promulgate the necessary rules and regulations for the 
administration of the acts (Sec. 6831-07). Violation of this law is 
a felony (Sec. 6831-08). 
North Da~ota -- North Dakota Century Code Anno., Vol. 3, 
Chapter 19, Article 19 et seq. 
North Dakota controls depressant drugs (Sec. 19-19-02) 
Anyone dispensing depressants must keep records of their depr;s-
sant drug inventory and records of sale (Sec. 19-19-06). These 
records are open to inspection for inspectors from the board of 
pharmacy (Sec. 19-19-07}. 
It is unlawful to illegally sell or distribute depressants 
or illegally possess barbiturates (Sec. 19-19-03). Penalty for 
violating the law is a misdemeanor. 
Ohio -- Page's Ohio Revised Code, Title 37, Sections 3719.23 
et seq.asamended. 
Depressants are controlled drugs in Ohio (Sec. 3719.23). 
Unlawful acts include: (1) illegal sale or distribution; and (2) 
illegal possession (Sec. 3719.24). Inventory and sale records 
must be kept for two years (Sec. 3719.26). These records can be 
inspected by authorized agents of the board of pharmacy (Sec. 
3719.27). Penalty for any violation of the provisions of this 
law is a misdemeanor (Sec. 3719.99 (I) (1967)). 
Oklahoma -- Oklahoma Statutes Anno., Title 63, Sections 
465.11 to 465.19 as amended. 
Oklahoma controls stimulant and depressant drugs (Sec. 63-
465.11). Unlawful acts include: (1) illegal possession; and (2) 
illegal sale or distribution (Sec. 63-465.12). Records are to be 
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kept for two years, and these records are open to inspection by 
agents of the board of pharmacy (Secs. 63-465.13 and 465.17). 
Violation of the act is a misdemeanor on the first offense and a 
felony for each subsequent offense (Sec. 63-465.19, 1966 amendment). 
Rhode Island -- General Laws of Rhode Island, Vol. 4, 
Sections 21-29-1 to 21-29-23. 
Rhode Island controls stimulants and depressants (Sec. 21-
29-2). Important unlawful acts are: (1) illegal possession; 
(2) illegal sale or distribution; and (3) failure to keep records 
(Sec. 21-29-3). Records of inventory and sales must be kept for 
two years (Sec. 21-29-8 and 21-29-9). Records are open to in-
spectors (Sec. 21-29-10). All unlawfully possessed stimulants or 
depressants are contraband and subject to seizure (Sec. 21-29-11). 
Any vessel, vehicle, or aircraft used in transportation of contra-
band is subject to forfeiture (Sec. 21-29-12). The board of 
pharmacy has the authority to make rules and regulations necessary 
to carry out provision of this law (Sec. 21-29-17). Any licensed 
physician or pharmacist violating this act may have his license 
suspended or revoked (Sec. 21-29-19). Unlawful sale of stimulants 
or depressants to a minor is a felony (Sec. 21-29-20). For viola-
tion of the general provisions of the law the penalty for first 
offense is a misdemeanor and each subsequent offense a felony 
(Sec. 21-29-21) . 
South Dakota -- South Dakota Code, 1960 Supp., Titl~ 22, 
Chapter 22.13A, Sections 22.13A01 to 22.13A09 as amended by chapter 
106 Session Laws of South Dakota 1965. 
Controlled drugs in South Dakota are depressants and stimu-
lants (Sec. 22.13A02 and 22.13Al0). Important unlawful acts in-
clude: (1) illegal sale or distribution; (2) illegal possession; 
and (3) failure to keep records (Secs. 22.13A03 and 22.13All). 
Records are to be kept for two years (Sec. 22.13A06), and records 
are to be open to inspection b) authorized agents of the state 
board of health (Sec. 22.13A07. Penalties for violation of this 
law are a misdemeanor on first offense and a felony for each sub-
sequent offense (Sec. 22.9933). 
Wisconsin -- Wisconsin Statutes 1965, Vol. 1, Chapter 151, 
Section 151.07. 
Dangerous drugs controlled in Wisconsin are stimulants and 
depressants (Sec. 151.07 (1) (a). Sale and possession of illegal 
dangerous drugs is prohibited (Sec. 151.07 (4), 151.07 (7). The 
state board of pharmacy is the administrator of the law (Sec. 
151.07 (9). Penalty for violation of the law is a misdemeanor 
(Sec. 151.07 (10). 
* In the compilation of dangerous drug laws of states, pages 46 through 56, the following shall apply: _unless otherwis~ stated 
a misdemeanor is any penalty with a maximum of $1,000 fine or 
one year imprisonment or both; unless otherwise stated, a felony 
is any penalty over $1,000 fine or one year imprisonment or both. 
-54-
